{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:21:47Z","timestamp":1792686107793,"version":"4.5.0"},"reference-count":234,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03878-1","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T13:02:10Z","timestamp":1716296530000},"page":"28-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hypogonadism and nonalcoholic fatty liver disease"],"prefix":"10.1007","volume":"86","author":[{"given":"Kasiani","family":"Papadimitriou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios C.","family":"Mousiolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesthimani","family":"Mintziori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Tarenidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"3878_CR1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","volume":"76","author":"JV Lazarus","year":"2022","unstructured":"J.V. Lazarus, H.E. Mark, M. Villota-Rivas, A. Palayew, P. Carrieri, M. Colombo, M. Ekstedt, G. Esmat, J. George, G. Marchesini, K. Novak, P. Ocama, V. Ratziu, H. Razavi, M. Romero-G\u00f3mez, M. Silva, C.W. Spearman, F. Tacke, E.A. Tsochatzis, Y. Yilmaz, Z.M. Younossi, V.W.S. Wong, S. Zelber-Sagi, H. Cortez-Pinto, Q.M. Anstee; NAFLD policy review collaborators, The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? J. Hepatol. 76, 771\u2013780 (2022). https:\/\/doi.org\/10.1016\/j.jhep.2021.10.025","journal-title":"J. Hepatol."},{"key":"3878_CR2","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","volume":"29","author":"ME Rinella","year":"2024","unstructured":"M.E. Rinella, J.V. Lazarus, V. Ratziu, S.M. Francque, A.J. Sanyal, F. Kanwal et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Ann. Hepatol. 29, 101133 (2024). https:\/\/doi.org\/10.1016\/j.aohep.2023.101133","journal-title":"Ann. Hepatol."},{"key":"3878_CR3","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","volume":"65","author":"Y Fazel","year":"2016","unstructured":"Y. Fazel, A.B. Koenig, M. Sayiner, Z.D. Goodman, Z.M. Younossi, Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism 65, 1017\u20131025 (2016). https:\/\/doi.org\/10.1016\/j.metabol.2016.01.012","journal-title":"Metabolism"},{"key":"3878_CR4","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.metabol.2016.02.013","volume":"65","author":"RS Khan","year":"2016","unstructured":"R.S. Khan, P.N. Newsome, Non-alcoholic fatty liver disease and liver transplantation. Metabolism 65, 1208\u20131223 (2016). https:\/\/doi.org\/10.1016\/j.metabol.2016.02.013","journal-title":"Metabolism"},{"key":"3878_CR5","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"N. Chalasani, Z. Younossi, J.E. Lavine, A.M. Diehl, E.M. Brunt, K. Cusi, M. Charlton, A.J. Sanyal, The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005\u20132023 (2012). https:\/\/doi.org\/10.1002\/hep.25762","journal-title":"Hepatology"},{"key":"3878_CR6","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1053\/j.gastro.2016.03.005","volume":"150","author":"Z Younossi","year":"2016","unstructured":"Z. Younossi, L. Henry, Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality. Gastroenterology 150, 1778\u20131785 (2016). https:\/\/doi.org\/10.1053\/j.gastro.2016.03.005","journal-title":"Gastroenterology"},{"key":"3878_CR7","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3390\/ijms20081948","volume":"20","author":"S Marchisello","year":"2019","unstructured":"S. Marchisello, A. Di Pino, R. Scicali, F. Urbano, S. Piro, F. Purrello, A.M. Rabuazzo, Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: An overview. Int J. Mol. Sci. 20, 1948 (2019). https:\/\/doi.org\/10.3390\/ijms20081948","journal-title":"Int J. Mol. Sci."},{"key":"3878_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"M. Eslam, P.N. Newsome, S.K. Sarin, Q.M. Anstee, G. Targher, M. Romero-Gomez, S. Zelber-Sagi, V. Wai-Sun Wong, J.F. Dufour, J.M. Schattenberg, T. Kawaguchi, M. Arrese, L. Valenti, G. Shiha, C. Tiribelli, H. Yki-J\u00e4rvinen, J.G. Fan, H. Gr\u00f8nb\u00e6k, Y. Yilmaz, H. Cortez-Pinto, C.P. Oliveira, P. Bedossa, L.A. Adams, M.H. Zheng, Y. Fouad, W.K. Chan, N. Mendez-Sanchez, S.H. Ahn, L. Castera, E. Bugianesi, V. Ratziu, J. George, A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J. Hepatol. 73, 202\u2013209 (2020). https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","journal-title":"J. Hepatol."},{"key":"3878_CR9","doi-asserted-by":"publisher","first-page":"1032361","DOI":"10.3389\/fendo.2022.1032361","volume":"13","author":"S Arefhosseini","year":"2022","unstructured":"S. Arefhosseini, M. Ebrahimi-Mameghani, F. Najafipour, H. Tutunchi, Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones. Front Endocrinol. (Lausanne) 13, 1032361 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.1032361","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"3878_CR10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/J.METABOL.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"E. Buzzetti, M. Pinzani, E.A. Tsochatzis, The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65, 1038\u20131048 (2016). https:\/\/doi.org\/10.1016\/J.METABOL.2015.12.012","journal-title":"Metabolism"},{"key":"3878_CR11","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.31518","volume":"73","author":"H Tilg","year":"2021","unstructured":"H. Tilg, T.E. Adolph, A.R. Moschen, Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade. Hepatology 73, 833\u2013842 (2021). https:\/\/doi.org\/10.1002\/hep.31518","journal-title":"Hepatology"},{"key":"3878_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","volume":"52","author":"E Makri","year":"2021","unstructured":"E. Makri, A. Goulas, S.A. Polyzos, Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease. Arch. Med Res 52, 25\u201337 (2021). https:\/\/doi.org\/10.1016\/j.arcmed.2020.11.010","journal-title":"Arch. Med Res"},{"key":"3878_CR13","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1530\/EJE-13-0296","volume":"169","author":"JM Hazlehurst","year":"2013","unstructured":"J.M. Hazlehurst, J.W. Tomlinson, Non-alcoholic fatty liver disease in common endocrine disorders. Eur. J. Endocrinol. 169, R27\u201337 (2013). https:\/\/doi.org\/10.1530\/EJE-13-0296","journal-title":"Eur. J. Endocrinol."},{"key":"3878_CR14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"A. Lonardo, F. Nascimbeni, S. Ballestri, D. Fairweather, S. Win, T.A. Than, M.F. Abdelmalek, A. Suzuki, Sex Differences in NAFLD: State of the Art and Identification of Research Gaps. Hepatology 70, 1457\u20131469 (2019)","journal-title":"Hepatology"},{"key":"3878_CR15","doi-asserted-by":"publisher","first-page":"294278","DOI":"10.1155\/2015\/294278","volume":"2015","author":"M Shen","year":"2015","unstructured":"M. Shen, H. Shi, Sex Hormones and Their Receptors Regulate Liver Energy Homeostasis. Int J. Endocrinol. 2015, 294278 (2015). https:\/\/doi.org\/10.1155\/2015\/294278","journal-title":"Int J. Endocrinol."},{"key":"3878_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molmet.2018.02.012","volume":"15","author":"A Maggi","year":"2018","unstructured":"A. Maggi, S. Della Torre, Sex, metabolism and health. Mol. Metab. 15, 3\u20137 (2018). https:\/\/doi.org\/10.1016\/j.molmet.2018.02.012","journal-title":"Mol. Metab."},{"key":"3878_CR17","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1111\/liv.14943","volume":"41","author":"P Burra","year":"2021","unstructured":"P. Burra, D. Bizzaro, A. Gonta, S. Shalaby, M. Gambato, M.C. Morelli, S. Trapani, A. Floreani, F. Marra, M.R. Brunetto, G. Taliani, E. Villa, Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Liver Int. 41, 1713\u20131733 (2021). https:\/\/doi.org\/10.1111\/liv.14943","journal-title":"Liver Int."},{"key":"3878_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.cnur.2018.04.006","volume":"53","author":"A Richard-Eaglin","year":"2018","unstructured":"A. Richard-Eaglin, Male and Female Hypogonadism. Nurs. Clin. North Am. 53, 395\u2013405 (2018). https:\/\/doi.org\/10.1016\/j.cnur.2018.04.006","journal-title":"Nurs. Clin. North Am."},{"key":"3878_CR19","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/andr.12770","volume":"8","author":"G Corona","year":"2020","unstructured":"G. Corona, D.G. Goulis, I. Huhtaniemi, M. Zitzmann, J. Toppari, G. Forti, D. Vanderschueren, F.C. Wu, European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males. Andrology 8, 970\u2013987 (2020). https:\/\/doi.org\/10.1111\/andr.12770","journal-title":"Andrology"},{"key":"3878_CR20","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1210\/jc.2017-00131","volume":"102","author":"CM Gordon","year":"2017","unstructured":"C.M. Gordon, K.E. Ackerman, S.L. Berga, J.R. Kaplan, G. Mastorakos, M. Misra, M.H. Murad, N.F. Santoro, M.P. Warren, Functional hypothalamic amenorrhea: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 102, 1413\u20131439 (2017). https:\/\/doi.org\/10.1210\/jc.2017-00131","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3878_CR21","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.3390\/ijerph17082620","volume":"17","author":"P Kur","year":"2020","unstructured":"P. Kur, A. Kolasa-Wo\u0142osiuk, K. Misiakiewicz-Has, B. Wiszniewska, Sex hormone-dependent physiology and diseases of liver. Int J. Environ. Res Public Health 17, 2620 (2020). https:\/\/doi.org\/10.3390\/ijerph17082620","journal-title":"Int J. Environ. Res Public Health"},{"key":"3878_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1210\/er.2018-00158","volume":"40","author":"M Grossmann","year":"2019","unstructured":"M. Grossmann, M.E. Wierman, P. Angus, D.J. Handelsman, Reproductive endocrinology of nonalcoholic fatty liver disease. Endocr. Rev. 40, 417\u2013446 (2019). https:\/\/doi.org\/10.1210\/er.2018-00158","journal-title":"Endocr. Rev."},{"key":"3878_CR23","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1210\/ME.2006-0007","volume":"20","author":"DJ Waxman","year":"2006","unstructured":"D.J. Waxman, C. O\u2019Connor, Growth hormone regulation of sex-dependent liver gene expression. Mol. Endocrinol. 20, 2613\u20132629 (2006). https:\/\/doi.org\/10.1210\/ME.2006-0007","journal-title":"Mol. Endocrinol."},{"key":"3878_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.23736\/S0391-1977.16.02570-0","volume":"42","author":"G Mintziori","year":"2017","unstructured":"G. Mintziori, P. Poulakos, C. Tsametis, D.G. Goulis, Hypogonadism and non-alcoholic fatty liver disease. Minerva Endocrinol. 42, 145\u2013150 (2017). https:\/\/doi.org\/10.23736\/S0391-1977.16.02570-0","journal-title":"Minerva Endocrinol."},{"key":"3878_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/J.1365-2265.1995.TB02040.X","volume":"43","author":"DJ Handelsman","year":"1995","unstructured":"D.J. Handelsman, S. Strasser, J.A. McDonald, A.J. Conway, G.W. McCaughan, Hypothalamic-pituitary-testicular function in end-stage non-alcoholic liver disease before and after liver transplantation. Clin. Endocrinol. (Oxf.) 43, 331\u2013337 (1995). https:\/\/doi.org\/10.1111\/J.1365-2265.1995.TB02040.X","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"3878_CR26","doi-asserted-by":"publisher","first-page":"100557","DOI":"10.1016\/J.AOHEP.2021.100557","volume":"26","author":"A Dokmak","year":"2021","unstructured":"A. Dokmak, H.D. Trivedi, A. Bonder, J. Wolf, Pregnancy in Chronic Liver Disease: Before and After Transplantation. Ann. Hepatol. 26, 100557 (2021). https:\/\/doi.org\/10.1016\/J.AOHEP.2021.100557","journal-title":"Ann. Hepatol."},{"key":"3878_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11102-008-0109-3","volume":"11","author":"MS Rothman","year":"2008","unstructured":"M.S. Rothman, M.E. Wierman, Female hypogonadism: Evaluation of the hypothalamic-pituitary-ovarian axis. Pituitary 11, 163\u2013169 (2008). https:\/\/doi.org\/10.1007\/s11102-008-0109-3","journal-title":"Pituitary"},{"key":"3878_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.maturitas.2019.03.008","volume":"123","author":"GD Mishra","year":"2019","unstructured":"G.D. Mishra, H.F. Chung, A. Cano, P. Chedraui, D.G. Goulis, P. Lopes, A. Mueck, M. Rees, L.M. Senturk, T. Simoncini, J.C. Stevenson, P. Stute, P. Tuomikoski, I. Lambrinoudaki, EMAS position statement: Predictors of premature and early natural menopause. Maturitas 123, 82\u201388 (2019). https:\/\/doi.org\/10.1016\/j.maturitas.2019.03.008","journal-title":"Maturitas"},{"key":"3878_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.maturitas.2021.06.012","volume":"151","author":"R Robeva","year":"2021","unstructured":"R. Robeva, D. Mladenovi\u0107, M. Veskovi\u0107, D. Hrn\u010di\u0107, J. Bjeki\u0107-Macut, O. Stanojlovi\u0107, S. Livadas, B.O. Yildiz, D. Macut, The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause. Maturitas 151, 22\u201330 (2021). https:\/\/doi.org\/10.1016\/j.maturitas.2021.06.012","journal-title":"Maturitas"},{"key":"3878_CR30","doi-asserted-by":"publisher","first-page":"e210537","DOI":"10.1530\/EC-21-0537","volume":"11","author":"P Anagnostis","year":"2022","unstructured":"P. Anagnostis, I. Lambrinoudaki, J.C. Stevenson, D.G. Goulis, Menopause-associated risk of cardiovascular disease. Endocr. Connect 11, e210537 (2022). https:\/\/doi.org\/10.1530\/EC-21-0537","journal-title":"Endocr. Connect"},{"key":"3878_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejogrb.2015.04.017","volume":"190","author":"S Ryu","year":"2015","unstructured":"S. Ryu, B.S. Suh, Y. Chang, M.J. Kwon, K.E. Yun, H.S. Jung, C.W. Kim, B.K. Kim, Y.J. Kim, Y. Choi, J. Ahn, Y.K. Cho, K.H. Kim, Y. Ahn, H.Y. Park, E.C. Chung, H. Shin, J. Cho, Menopausal stages and non-alcoholic fatty liver disease in middle-aged women. Eur. J. Obst Gynecol. Rep. Biol. 190, 65\u201370 (2015). https:\/\/doi.org\/10.1016\/j.ejogrb.2015.04.017","journal-title":"Eur. J. Obst Gynecol. Rep. Biol."},{"key":"3878_CR32","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.26761","volume":"59","author":"JD Yang","year":"2014","unstructured":"J.D. Yang, M.F. Abdelmalek, H. Pang, C.D. Guy, A.D. Smith, A.M. Diehl, A. Suzuki, Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology 59, 1406\u20131414 (2014). https:\/\/doi.org\/10.1002\/hep.26761","journal-title":"Hepatology"},{"key":"3878_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/hep.28514","volume":"64","author":"JS Klair","year":"2016","unstructured":"J.S. Klair, J.D. Yang, M.F. Abdelmalek, C.D. Guy, R.M. Gill, K. Yates, A. Unalp-Arida, J.E. Lavine, J.M. Clark, A.M. Diehl, A. Suzuki, A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatology 64, 85\u201391 (2016). https:\/\/doi.org\/10.1002\/hep.28514","journal-title":"Hepatology"},{"key":"3878_CR34","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.cgh.2020.08.012","volume":"19","author":"J Wang","year":"2021","unstructured":"J. Wang, A.H. Wu, F.Z. Stanczyk, J. Porcel, M. Noureddin, N.A. Terrault, L.R. Wilkens, V.W. Setiawan, Associations Between Reproductive and Hormone-Related Factors and Risk of Nonalcoholic Fatty Liver Disease in a Multiethnic Population. Clin. Gastroenterol. Hepatol. 19, 1258\u20131266 (2021). https:\/\/doi.org\/10.1016\/j.cgh.2020.08.012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"3878_CR35","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10654-019-00526-1","volume":"34","author":"AA Florio","year":"2019","unstructured":"A.A. Florio, B.I. Graubard, B. Yang, J.E. Thistle, M.C. Bradley, K.A. McGlynn, J.L. Petrick, Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink. Eur. J. Epidemiol. 34, 871\u2013878 (2019). https:\/\/doi.org\/10.1007\/s10654-019-00526-1","journal-title":"Eur. J. Epidemiol."},{"key":"3878_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1136\/gut.32.2.202","volume":"32","author":"TF Cundy","year":"1991","unstructured":"T.F. Cundy, J. Butler, R.M. Pope, A.K. Saggar-Malik, M.J. Wheeler, R. Williams, Amenorrhoea in women with non-alcoholic chronic liver disease. Gut 32, 202\u2013206 (1991). https:\/\/doi.org\/10.1136\/gut.32.2.202","journal-title":"Gut"},{"key":"3878_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/medsci9020039","volume":"9","author":"S Kalra","year":"2021","unstructured":"S. Kalra, S. Bhattacharya, P. Rawal, Hepatocrinology. Med Sci. 9, 39 (2021). https:\/\/doi.org\/10.3390\/medsci9020039","journal-title":"Med Sci."},{"key":"3878_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-021-04104-w","volume":"21","author":"I Marzec","year":"2021","unstructured":"I. Marzec, A. S\u0142owakiewicz, J. Gozdowska, O. Tronina, M. Pacholczyk, W. Lisik, A. Fleming, M. Durlik, Pregnancy after liver transplant: maternal and perinatal outcomes. BMC Preg Childbirth 21, 627 (2021). https:\/\/doi.org\/10.1186\/s12884-021-04104-w","journal-title":"BMC Preg Childbirth"},{"key":"3878_CR39","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s40519-020-01060-w","volume":"26","author":"R Risi","year":"2021","unstructured":"R. Risi, D. Tuccinardi, S. Mariani, C. Lubrano, S. Manfrini, L.M. Donini, M. Watanabe, Liver disease in obesity and underweight: the two sides of the coin. A narrative review. Eat. Weight Disord. 26, 2097\u20132107 (2021). https:\/\/doi.org\/10.1007\/s40519-020-01060-w","journal-title":"Eat. Weight Disord."},{"key":"3878_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.metabol.2019.05.001","volume":"96","author":"SA Polyzos","year":"2019","unstructured":"S.A. Polyzos, N. Perakakis, C.S. Mantzoros, Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and\/or leptin replacement. Metabolism 96, 66\u201382 (2019). https:\/\/doi.org\/10.1016\/j.metabol.2019.05.001","journal-title":"Metabolism"},{"key":"3878_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jendso\/bvac124","volume":"6","author":"I Fedor","year":"2022","unstructured":"I. Fedor, E. Zold, Z. Barta, Liver Abnormalities in Turner Syndrome: The Importance of Estrogen Replacement. J. Endocr. Soc. 6, 1\u20137 (2022). https:\/\/doi.org\/10.1210\/jendso\/bvac124","journal-title":"J. Endocr. Soc."},{"key":"3878_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/BS.APCSB.2019.01.001","volume":"116","author":"N Fuentes","year":"2019","unstructured":"N. Fuentes, P. Silveyra, Estrogen receptor signaling mechanisms. Adv. Protein Chem. Struct. Biol. 116, 135\u2013170 (2019). https:\/\/doi.org\/10.1016\/BS.APCSB.2019.01.001","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"3878_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/J.MCE.2019.04.005","volume":"490","author":"V Khristi","year":"2019","unstructured":"V. Khristi, A. Ratri, S. Ghosh, D. Pathak, S. Borosha, E. Dai, R. Roy, V.P. Chakravarthi, M.W. Wolfe, M.A. Karim Rumi, Disruption of ESR1 alters the expression of genes regulating hepatic lipid and carbohydrate metabolism in male rats. Mol. Cell Endocrinol. 490, 47\u201356 (2019). https:\/\/doi.org\/10.1016\/J.MCE.2019.04.005","journal-title":"Mol. Cell Endocrinol."},{"key":"3878_CR44","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/J.CELREP.2016.03.019","volume":"15","author":"S Della Torre","year":"2016","unstructured":"S. Della Torre, N. Mitro, R. Fontana, M. Gomaraschi, E. Favari, C. Recordati, F. Lolli, F. Quagliarini, C. Meda, C. Ohlsson, M. Crestani, N.H. Uhlenhaut, L. Calabresi, A. Maggi, An Essential Role for Liver ER\u03b1 in Coupling Hepatic Metabolism to the Reproductive Cycle. Cell Rep. 15, 360\u2013371 (2016). https:\/\/doi.org\/10.1016\/J.CELREP.2016.03.019","journal-title":"Cell Rep."},{"key":"3878_CR45","doi-asserted-by":"publisher","first-page":"572490","DOI":"10.3389\/fendo.2020.572490","volume":"11","author":"S Della Torre","year":"2020","unstructured":"S. Della Torre, Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. Front Endocrinol. (Lausanne) 11, 572490 (2020). https:\/\/doi.org\/10.3389\/fendo.2020.572490","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"3878_CR46","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/J.FREERADBIOMED.2020.02.016","volume":"150","author":"BM Galm\u00e9s-Pascual","year":"2020","unstructured":"B.M. Galm\u00e9s-Pascual, M.R. Mart\u00ednez-Cignoni, A. Mor\u00e1n-Costoya, M. Bauza-Thorbr\u00fcgge, M. Sbert-Roig, A. Valle, A.M. Proenza, I. Llad\u00f3, M. Gianotti, 17\u03b2-estradiol ameliorates lipotoxicity-induced hepatic mitochondrial oxidative stress and insulin resistance. Free Radic. Biol. Med 150, 148\u2013160 (2020). https:\/\/doi.org\/10.1016\/J.FREERADBIOMED.2020.02.016","journal-title":"Free Radic. Biol. Med"},{"key":"3878_CR47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1161\/HH2101.098543","volume":"89","author":"MJ Evans","year":"2001","unstructured":"M.J. Evans, A. Eckert, K. Lai, S.J. Adelman, D.C. Harnish, Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo. Circ. Res 89, 823\u2013830 (2001). https:\/\/doi.org\/10.1161\/HH2101.098543","journal-title":"Circ. Res"},{"key":"3878_CR48","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3892\/MMR.2016.5966","volume":"15","author":"H Yan","year":"2017","unstructured":"H. Yan, Y. Gao, Y. Zhang, Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease. Mol. Med Rep. 15, 180\u2013186 (2017). https:\/\/doi.org\/10.3892\/MMR.2016.5966","journal-title":"Mol. Med Rep."},{"key":"3878_CR49","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.1172\/JCI128289","volume":"129","author":"S Win","year":"2019","unstructured":"S. Win, R.W.M. Min, C.Q. Chen, J. Zhang, Y. Chen, M. Li, A. Suzuki, M.F. Abdelmalek, Y. Wang, M. Aghajan, F.W.M. Aung, A.M. Diehl, R.J. Davis, T.A. Than, N. Kaplowitz, Expression of mitochondrial membrane-linked SAB determines severity of sex-dependent acute liver injury. J. Clin. Invest 129, 5278\u20135293 (2019). https:\/\/doi.org\/10.1172\/JCI128289","journal-title":"J. Clin. Invest"},{"key":"3878_CR50","doi-asserted-by":"publisher","first-page":"e13236","DOI":"10.1111\/eci.13236","volume":"50","author":"S Ministrini","year":"2020","unstructured":"S. Ministrini, F. Montecucco, A. Sahebkar, F. Carbone, Macrophages in the pathophysiology of NAFLD: The role of sex differences. Eur. J. Clin. Invest 50, e13236 (2020). https:\/\/doi.org\/10.1111\/eci.13236","journal-title":"Eur. J. Clin. Invest"},{"key":"3878_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep15224","volume":"5","author":"A Villa","year":"2015","unstructured":"A. Villa, N. Rizzi, E. Vegeto, P. Ciana, A. Maggi, Estrogen accelerates the resolution of inflammation in macrophagic cells. Sci. Rep. 5, 1\u201314 (2015). https:\/\/doi.org\/10.1038\/srep15224","journal-title":"Sci. Rep."},{"key":"3878_CR52","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2353\/ajpath.2006.060010","volume":"169","author":"F Hildebrand","year":"2006","unstructured":"F. Hildebrand, W.J. Hubbard, M.A. Choudhry, M. Frink, H.C. Pape, S.L. Kunkel, I.H. Chaudry, Kupffer cells and their mediators: The culprits in producing distant organ damage after trauma-hemorrhage. Am. J. Pathol. 169, 784\u2013794 (2006). https:\/\/doi.org\/10.2353\/ajpath.2006.060010","journal-title":"Am. J. Pathol."},{"key":"3878_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/gut.44.1.127","volume":"44","author":"I Shimizu","year":"1999","unstructured":"I. Shimizu, Y. Mizobuchi, M. Yasuda, M. Shiba, Y.R. Ma, T. Horie, F. Liu, S. Ito, Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut 44, 127\u201336 (1999). https:\/\/doi.org\/10.1136\/gut.44.1.127","journal-title":"Gut"},{"key":"3878_CR54","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/jgh.13976","volume":"33","author":"B Zhang","year":"2018","unstructured":"B. Zhang, C.G. Zhang, L.H. Ji, G. Zhao, Z.Y. Wu, Estrogen receptor \u03b2 selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells. J. Gastroenterol. Hepatol. (Aust.) 33, 747\u2013755 (2018). https:\/\/doi.org\/10.1111\/jgh.13976","journal-title":"J. Gastroenterol. Hepatol. (Aust.)"},{"key":"3878_CR55","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s42000-022-00369-8","volume":"21","author":"SA Polyzos","year":"2022","unstructured":"S.A. Polyzos, I. Lambrinoudaki, D.G. Goulis, Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease. Hormones 21, 375\u2013381 (2022). https:\/\/doi.org\/10.1007\/s42000-022-00369-8","journal-title":"Hormones"},{"key":"3878_CR56","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/labinvest.2015.63","volume":"95","author":"Q Wei","year":"2015","unstructured":"Q. Wei, P. Guo, K. Mu, Y. Zhang, W. Zhao, W. Huai, Y. Qiu, T. Li, X. Ma, Y. Liu, X. Chen, L. Han, Estrogen suppresses hepatocellular carcinoma cells through ER\u03b2-mediated upregulation of the NLRP3 inflammasome. Lab. Investig. 95, 804\u2013816 (2015). https:\/\/doi.org\/10.1038\/labinvest.2015.63","journal-title":"Lab. Investig."},{"key":"3878_CR57","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ijc.32723","volume":"147","author":"JL Petrick","year":"2020","unstructured":"J.L. Petrick, A.A. Florio, A. Znaor, D. Ruggieri, M. Laversanne, C.S. Alvarez, J. Ferlay, P.C. Valery, F. Bray, K.A. McGlynn, International trends in hepatocellular carcinoma incidence, 1978\u20132012. Int J. Cancer 147, 317\u2013330 (2020). https:\/\/doi.org\/10.1002\/ijc.32723","journal-title":"Int J. Cancer"},{"key":"3878_CR58","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1097\/GME.0B013E31817B8159","volume":"15","author":"A Paquette","year":"2008","unstructured":"A. Paquette, D. Wang, M. Jankowski, J. Gutkowska, J.M. Lavoie, Effects of ovariectomy on PPAR alpha, SREBP-1c, and SCD-1 gene expression in the rat liver. Menopause 15, 1169\u20131175 (2008). https:\/\/doi.org\/10.1097\/GME.0B013E31817B8159","journal-title":"Menopause"},{"key":"3878_CR59","doi-asserted-by":"publisher","first-page":"35983","DOI":"10.1074\/JBC.M507339200","volume":"280","author":"TM D\u2019Eon","year":"2005","unstructured":"T.M. D\u2019Eon, S.C. Souza, M. Aronovitz, M.S. Obin, S.K. Fried, A.S. Greenberg, Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J. Biol. Chem. 280, 35983\u201335991 (2005). https:\/\/doi.org\/10.1074\/JBC.M507339200","journal-title":"J. Biol. Chem."},{"key":"3878_CR60","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2337\/DB11-1718","volume":"62","author":"L Zhu","year":"2013","unstructured":"L. Zhu, W.C. Brown, Q. Cai, A. Krust, P. Chambon, O.P. McGuinness, J.M. Stafford, Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes 62, 424\u2013434 (2013). https:\/\/doi.org\/10.2337\/DB11-1718","journal-title":"Diabetes"},{"key":"3878_CR61","doi-asserted-by":"publisher","first-page":"G1031","DOI":"10.1152\/ajpgi.00211.2011","volume":"301","author":"Y Kamada","year":"2011","unstructured":"Y. Kamada, S. Kiso, Y. Yoshida, N. Chatani, T. Kizu, M. Hamano, M. Tsubakio, T. Takemura, H. Ezaki, N. Hayashi, T. Takehara, Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet. Am. J. Physiol.-Gastrointest. Liver Physiol. 301, G1031\u201343 (2011). https:\/\/doi.org\/10.1152\/ajpgi.00211.2011","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"3878_CR62","doi-asserted-by":"publisher","first-page":"E304","DOI":"10.1152\/AJPENDO.00504.2009","volume":"298","author":"V Ribas","year":"2010","unstructured":"V. Ribas, M.T.A. Nguyen, D.C. Henstridge, A.K. Nguyen, S.W. Beaven, M.J. Watt, A.L. Hevener, Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am. J. Physiol. Endocrinol. Metab. 298, E304\u2013319 (2010). https:\/\/doi.org\/10.1152\/AJPENDO.00504.2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"3878_CR63","doi-asserted-by":"publisher","unstructured":"G. Bryzgalova, H. Gao, B. Ahren, J.R. Zierath, D. Galuska, T.L. Steiler, K. Dahlman-Wright, S. Nilsson, J.\u00c5. Gustafsson, S. Efendic, A. Khan, Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49, 588\u2013597 (2006). https:\/\/doi.org\/10.1007\/S00125-005-0105-3","DOI":"10.1007\/S00125-005-0105-3"},{"key":"3878_CR64","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/ijo.2017.50","volume":"41","author":"S Hart-Unger","year":"2017","unstructured":"S. Hart-Unger, Y. Arao, K.J. Hamilton, S.L. Lierz, D.E. Malarkey, S.C. Hewitt, M. Freemark, K.S. Korach, Hormone signaling and fatty liver in females: Analysis of estrogen receptor \u03b1 mutant mice. Int J. Obes. 41, 945\u2013954 (2017). https:\/\/doi.org\/10.1038\/ijo.2017.50","journal-title":"Int J. Obes."},{"key":"3878_CR65","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/J.MATURITAS.2010.08.003","volume":"67","author":"CM Gameiro","year":"2010","unstructured":"C.M. Gameiro, F. Rom\u00e3o, C. Castelo-Branco, Menopause and aging: changes in the immune system\u2013a review. Maturitas 67, 316\u2013320 (2010). https:\/\/doi.org\/10.1016\/J.MATURITAS.2010.08.003","journal-title":"Maturitas"},{"key":"3878_CR66","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/HEP.510290307","volume":"29","author":"M Yasuda","year":"1999","unstructured":"M. Yasuda, I. Shimizu, M. Shiba, S. Ito, Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 29, 719\u2013727 (1999). https:\/\/doi.org\/10.1002\/HEP.510290307","journal-title":"Hepatology"},{"key":"3878_CR67","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1136\/GUT.2005.053278","volume":"54","author":"T Itagaki","year":"2005","unstructured":"T. Itagaki, I. Shimizu, X. Cheng, Y. Yuan, A. Oshio, K. Tamaki, H. Fukuno, H. Honda, Y. Okamura, S. Ito, Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells. Gut 54, 1782\u20131789 (2005). https:\/\/doi.org\/10.1136\/GUT.2005.053278","journal-title":"Gut"},{"key":"3878_CR68","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/bf03401306","volume":"12","author":"SA Polyzos","year":"2013","unstructured":"S.A. Polyzos, J. Kountouras, A. Tsatsoulis, E. Zafeiriadou, E. Katsiki, K. Patsiaoura, C. Zavos, V.V. Anastasiadou, A. Slavakis, Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease. Hormones 12, 405\u2013416 (2013). https:\/\/doi.org\/10.1007\/bf03401306","journal-title":"Hormones"},{"key":"3878_CR69","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/hep.27097","volume":"60","author":"M Yoneda","year":"2014","unstructured":"M. Yoneda, E. Thomas, Y. Sumida, Y. Eguchi, E.R. Schiff, The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease. Hepatology 60, 1792 (2014). https:\/\/doi.org\/10.1002\/hep.27097","journal-title":"Hepatology"},{"key":"3878_CR70","doi-asserted-by":"publisher","first-page":"711137","DOI":"10.3389\/fmicb.2021.711137","volume":"12","author":"S He","year":"2021","unstructured":"S. He, H. Li, Z. Yu, F. Zhang, S. Liang, H. Liu, H. Chen, M.H. L\u00fc, The Gut Microbiome and Sex Hormone-Related Diseases. Front Microbiol 12, 711137 (2021). https:\/\/doi.org\/10.3389\/fmicb.2021.711137","journal-title":"Front Microbiol"},{"key":"3878_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/S40168-020-00913-X","volume":"8","author":"J Mayneris-Perxachs","year":"2020","unstructured":"J. Mayneris-Perxachs, M. Arnoriaga-Rodr\u00edguez, D. Luque-C\u00f3rdoba, F. Priego-Capote, V. P\u00e9rez-Brocal, A. Moya, A. Burokas, R. Maldonado, J.M. Fern\u00e1ndez-Real, Gut microbiota steroid sexual dimorphism and its impact on gonadal steroids: influences of obesity and menopausal status. Microbiome 8, 136 (2020). https:\/\/doi.org\/10.1186\/S40168-020-00913-X","journal-title":"Microbiome"},{"key":"3878_CR72","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/J.MATURITAS.2018.07.008","volume":"116","author":"JA Santos-Marcos","year":"2018","unstructured":"J.A. Santos-Marcos, O.A. Rangel-Zu\u00f1iga, R. Jimenez-Lucena, G.M. Quintana-Navarro, S. Garcia-Carpintero, M.M. Malagon, B.B. Landa, M. Tena-Sempere, P. Perez-Martinez, J. Lopez-Miranda, F. Perez-Jimenez, A. Camargo, Influence of gender and menopausal status on gut microbiota. Maturitas 116, 43\u201353 (2018). https:\/\/doi.org\/10.1016\/J.MATURITAS.2018.07.008","journal-title":"Maturitas"},{"key":"3878_CR73","doi-asserted-by":"publisher","first-page":"e26991","DOI":"10.1016\/J.HELIYON.2024.E26991","volume":"10","author":"X Li","year":"2024","unstructured":"X. Li, M. He, X. Yi, X. Lu, M. Zhu, M. Xue, Y. Tang, Y. Zhu, Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targets. Heliyon 10, e26991 (2024). https:\/\/doi.org\/10.1016\/J.HELIYON.2024.E26991","journal-title":"Heliyon"},{"key":"3878_CR74","doi-asserted-by":"publisher","first-page":"e0262855","DOI":"10.1371\/journal.pone.0262855","volume":"17","author":"L Liu","year":"2022","unstructured":"L. Liu, Q. Fu, T. Li, K. Shao, X. Zhu, Y. Cong, X. Zhao, Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency. PLoS One 17, e0262855 (2022). https:\/\/doi.org\/10.1371\/journal.pone.0262855","journal-title":"PLoS One"},{"key":"3878_CR75","doi-asserted-by":"publisher","first-page":"2295429","DOI":"10.1080\/19490976.2023.2295429","volume":"16","author":"TWL Cross","year":"2024","unstructured":"T.W.L. Cross, A.M.R. Simpson, C.Y. Lin, N.M. Hottmann, A.P. Bhatt, S.J. Pellock, E.R. Nelson, B.R. Loman, M.A. Wallig, E.I. Vivas, J. Suchodolski, M.R. Redinbo, F.E. Rey, K.S. Swanson, Gut microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction. Gut Microbes 16, 2295429 (2024). https:\/\/doi.org\/10.1080\/19490976.2023.2295429","journal-title":"Gut Microbes"},{"key":"3878_CR76","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1538\/expanim.20-0028","volume":"69","author":"T Watahiki","year":"2020","unstructured":"T. Watahiki, K. Okada, E. Warabi, T. Nagaoka, H. Suzuki, K. Ishige, T. Yanagawa, S. Takahashi, Y. Mizokami, K. Tokushige, S.I. Ariizumi, M. Yamamoto, J. Shoda, Gender difference in development of steatohepatitis in p62\/sqstm1 and nrf2 double-knockout mice. Exp. Anim. 69, 395\u2013406 (2020). https:\/\/doi.org\/10.1538\/expanim.20-0028","journal-title":"Exp. Anim."},{"key":"3878_CR77","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/HEP.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"H. Tilg, A.R. Moschen, Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836\u20131846 (2010). https:\/\/doi.org\/10.1002\/HEP.24001","journal-title":"Hepatology"},{"key":"3878_CR78","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2174\/1570161116666180711121949","volume":"17","author":"V Venetsanaki","year":"2018","unstructured":"V. Venetsanaki, S.A. Polyzos, Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives. Curr. Vasc. Pharm. 17, 546\u2013555 (2018). https:\/\/doi.org\/10.2174\/1570161116666180711121949","journal-title":"Curr. Vasc. Pharm."},{"key":"3878_CR79","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jsbmb.2013.04.001","volume":"138","author":"N Kanaya","year":"2013","unstructured":"N. Kanaya, S. Vonderfecht, S. Chen, Androgen (dihydrotestosterone)-mediated regulation of food intake and obesity in female mice. J. Steroid Biochem. Mol. Biol. 138, 100\u2013106 (2013). https:\/\/doi.org\/10.1016\/j.jsbmb.2013.04.001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"3878_CR80","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.cgh.2014.12.033","volume":"13","author":"M Lazo","year":"2015","unstructured":"M. Lazo, I. Zeb, K. Nasir, R.P. Tracy, M.J. Budoff, P. Ouyang, D. Vaidya, The association of endogenous sex hormones with liver fat - multi-ethnic study of atherosclerosis (MESA). Clin. Gastroenterol. Hepatol 13, 1686\u20131693.e2 (2015). https:\/\/doi.org\/10.1016\/j.cgh.2014.12.033","journal-title":"Clin. Gastroenterol. Hepatol"},{"key":"3878_CR81","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.5114\/aoms.2017.68972","volume":"13","author":"A Klisic","year":"2017","unstructured":"A. Klisic, N. Kavaric, M. Jovanovic, I. Soldatovic, N. Gligorovic-Barhanovic, J. Kotur-Stevuljevic, Bioavailable testosterone is independently associated with Fatty Liver Index in postmenopausal women. Arch. Med. Sci. 13, 1188\u20131196 (2017). https:\/\/doi.org\/10.5114\/aoms.2017.68972","journal-title":"Arch. Med. Sci."},{"key":"3878_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2022.1053709","volume":"13","author":"MJ Song","year":"2022","unstructured":"M.J. Song, J.Y. Choi, Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin. Front Endocrinol. (Lausanne) 13, 1\u20138 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.1053709","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"3878_CR83","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0960-0760(99)00070-9","volume":"69","author":"W Rosner","year":"1999","unstructured":"W. Rosner, D.J. Hryb, M.S. Khan, A.M. Nakhla, N.A. Romas, Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J. Steroid Biochem Mol. Biol. 69, 481\u2013485 (1999). https:\/\/doi.org\/10.1016\/S0960-0760(99)00070-9","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"3878_CR84","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/J.CELL.2005.06.032","volume":"122","author":"A Hammes","year":"2005","unstructured":"A. Hammes, T.K. Andreassen, R. Spoelgen, J. Raila, N. Hubner, H. Schulz, J. Metzger, F.J. Schweigert, P.B. Luppa, A. Nykjaer, T.E. Willnow, Role of endocytosis in cellular uptake of sex steroids. Cell 122, 751\u2013762 (2005). https:\/\/doi.org\/10.1016\/J.CELL.2005.06.032","journal-title":"Cell"},{"key":"3878_CR85","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0026-0495(97)90159-1","volume":"46","author":"R Pasquali","year":"1997","unstructured":"R. Pasquali, V. Vicennati, D. Bertazzo, F. Casimirri, G. Pascal, O. Tortelli, A.M. Morselli Labate, Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Metabolism 46, 5\u20139 (1997). https:\/\/doi.org\/10.1016\/S0026-0495(97)90159-1","journal-title":"Metabolism"},{"key":"3878_CR86","doi-asserted-by":"publisher","unstructured":"M. Ramon-Krauel, M.J. Leal-Witt, \u00d3. Conles, M. Amat-Bou, C. Lerin, D.M. Selva, Relationship between adiponectin, TNF\u03b1, and SHBG in prepubertal children with obesity. Mol. Cell Pediatr. 8, 3 (2021). https:\/\/doi.org\/10.1186\/S40348-021-00113-Z","DOI":"10.1186\/S40348-021-00113-Z"},{"key":"3878_CR87","doi-asserted-by":"publisher","first-page":"34105","DOI":"10.1074\/JBC.273.51.34105","volume":"273","author":"M J\u00e4nne","year":"1998","unstructured":"M. J\u00e4nne, G.L. Hammond, Hepatocyte nuclear factor-4 controls transcription from a TATA-less human sex hormone-binding globulin gene promoter. J. Biol. Chem. 273, 34105\u201334114 (1998). https:\/\/doi.org\/10.1074\/JBC.273.51.34105","journal-title":"J. Biol. Chem."},{"key":"3878_CR88","doi-asserted-by":"publisher","first-page":"3062319","DOI":"10.1155\/2018\/3062319","volume":"2018","author":"H Yamazaki","year":"2018","unstructured":"H. Yamazaki, A. Kushiyama, H. Sakoda, M. Fujishiro, T. Yamamotoya, Y. Nakatsu, T. Kikuchi, S. Kaneko, H. Tanaka, T. Asano, Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome: In Vitro Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and Macrophages. Mediators Inflamm. 2018, 3062319 (2018). https:\/\/doi.org\/10.1155\/2018\/3062319","journal-title":"Mediators Inflamm."},{"key":"3878_CR89","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5604\/16652681.1235481","volume":"16","author":"V Jaruvongvanich","year":"2017","unstructured":"V. Jaruvongvanich, A. Sanguankeo, T. Riangwiwat, S. Upala, Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: A systematic review and meta-analysis. Ann. Hepatol. 16, 382\u2013394 (2017). https:\/\/doi.org\/10.5604\/16652681.1235481","journal-title":"Ann. Hepatol."},{"key":"3878_CR90","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1210\/clinem\/dgaa574","volume":"105","author":"NT Mueller","year":"2020","unstructured":"N.T. Mueller, T. Liu, E.B. Mitchel, K.P. Yates, A. Suzuki, C. Behling, J.E. Lavine, Sex Hormone Relations to Histologic Severity of Pediatric Nonalcoholic Fatty Liver Disease. J. Clin. Endocrinol. Metab. 105, 3496\u20133504 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa574","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3878_CR91","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/00007890-199608270-00009","volume":"62","author":"K Mass","year":"1996","unstructured":"K. Mass, E.H. Quint, M.R. Punch, R.M. Merion, Gynecological and reproductive function after liver. Transplant. 62, 476\u2013479 (1996). https:\/\/doi.org\/10.1097\/00007890-199608270-00009","journal-title":". Transplant."},{"key":"3878_CR92","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1530\/EJE.0.1320444","volume":"132","author":"H Bell","year":"1995","unstructured":"H. Bell, N. Raknerud, J.A. Falch, E. Haug, Inappropriately low levels of gonadotrophins in amenorrhoeic women with alcoholic and non-alcoholic cirrhosis. Eur. J. Endocrinol. 132, 444\u2013449 (1995). https:\/\/doi.org\/10.1530\/EJE.0.1320444","journal-title":"Eur. J. Endocrinol."},{"key":"3878_CR93","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/BF03345694","volume":"32","author":"G De Pergola","year":"2009","unstructured":"G. De Pergola, M. Tartagni, F. D\u2019Angelol, C. Centoducati, P. Guida, R.: Giorgino, Abdominal fat accumulation, and not insulin resistance, is associated to oligomenorrhea in non-hyperandrogenic overweight\/obese women. J. Endocrinol. Invest 32, 98\u2013101 (2009). https:\/\/doi.org\/10.1007\/BF03345694","journal-title":"J. Endocrinol. Invest"},{"key":"3878_CR94","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/J.FERTNSTERT.2005.09.065","volume":"85","author":"E Budak","year":"2006","unstructured":"E. Budak, M. Fern\u00e1ndez S\u00e1nchez, J. Bellver, A. Cerver\u00f3, C. Sim\u00f3n, A. Pellicer, Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil. Steril. 85, 1563\u20131581 (2006). https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2005.09.065","journal-title":"Fertil. Steril."},{"key":"3878_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-018-0336-z","volume":"16","author":"E Silvestris","year":"2018","unstructured":"E. Silvestris, G. de Pergola, R. Rosania, G. Loverro, Obesity as disruptor of the female fertility. Reprod. Biol. Endocrinol. 16, 1\u201313 (2018). https:\/\/doi.org\/10.1186\/s12958-018-0336-z","journal-title":"Reprod. Biol. Endocrinol."},{"key":"3878_CR96","doi-asserted-by":"publisher","first-page":"E520","DOI":"10.1210\/CLINEM\/DGAA792","volume":"106","author":"TL Stanley","year":"2021","unstructured":"T.L. Stanley, L.T. Fourman, I. Zheng, C.M. McClure, M.N. Feldpausch, M. Torriani, K.E. Corey, R.T. Chung, H. Lee, D.E. Kleiner, C.M. Hadigan, S.K. Grinspoon, Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease. J. Clin. Endocrinol. Metab. 106, E520\u2013E533 (2021). https:\/\/doi.org\/10.1210\/CLINEM\/DGAA792","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3878_CR97","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/OBY.2006.228","volume":"14","author":"G De Pergola","year":"2006","unstructured":"G. De Pergola, S. Maldera, M. Tartagni, N. Pannacciulli, G. Loverro, R.: Giorgino, Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women. Obes. (Silver Spring) 14, 1954\u20131960 (2006). https:\/\/doi.org\/10.1038\/OBY.2006.228","journal-title":"Obes. (Silver Spring)"},{"key":"3878_CR98","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/J.METABOL.2019.153947","volume":"99","author":"N Nikolaou","year":"2019","unstructured":"N. Nikolaou, L.L. Gathercole, L. Marchand, S. Althari, N.J. Dempster, C.J. Green, M. van de Bunt, C. McNeil, A. Arvaniti, B.A. Hughes, B. Sgromo, R.S. Gillies, H.U. Marschall, T.M. Penning, J. Ryan, W. Arlt, L. Hodson, J.W. Tomlinson, AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease. Metabolism 99, 67\u201380 (2019). https:\/\/doi.org\/10.1016\/J.METABOL.2019.153947","journal-title":"Metabolism"},{"key":"3878_CR99","doi-asserted-by":"publisher","first-page":"105724","DOI":"10.1016\/J.JSBMB.2020.105724","volume":"202","author":"L Barnard","year":"2020","unstructured":"L. Barnard, N. Nikolaou, C. Louw, L. Schiffer, H. Gibson, L.C. Gilligan, E. Gangitano, J. Snoep, W. Arlt, J.W. Tomlinson, K.H. Storbeck, The A-ring reduction of 11-ketotestosterone is efficiently catalysed by AKR1D1 and SRD5A2 but not SRD5A1. J. Steroid Biochem Mol. Biol. 202, 105724 (2020). https:\/\/doi.org\/10.1016\/J.JSBMB.2020.105724","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"3878_CR100","doi-asserted-by":"publisher","first-page":"437","DOI":"10.7555\/JBR.31.20170031","volume":"31","author":"SR Lee","year":"2017","unstructured":"S.R. Lee, S.Y. Lee, S.Y. Kim, S.Y. Ryu, B.K. Park, E.J. Hong, Hydroxylation and sulfation of sex steroid hormones in inflammatory liver. J. Biomed. Res. 31, 437\u2013444 (2017). https:\/\/doi.org\/10.7555\/JBR.31.20170031","journal-title":"J. Biomed. Res."},{"key":"3878_CR101","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1002\/HEP.30359","volume":"69","author":"SF Neong","year":"2019","unstructured":"S.F. Neong, E.O. Billington, S.E. Congly, Sexual Dysfunction and Sex Hormone Abnormalities in Patients With Cirrhosis: Review of Pathogenesis and Management. Hepatology 69, 2683\u20132695 (2019). https:\/\/doi.org\/10.1002\/HEP.30359","journal-title":"Hepatology"},{"key":"3878_CR102","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3748\/wjg.v18.i3.237","volume":"18","author":"M Hamaguchi","year":"2012","unstructured":"M. Hamaguchi, T. Kojima, A. Ohbora, N. Takeda, M. Fukui, T. Kato, Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J. Gastroenterol. 18, 237\u2013243 (2012). https:\/\/doi.org\/10.3748\/wjg.v18.i3.237","journal-title":"World J. Gastroenterol."},{"key":"3878_CR103","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1590\/S0004-28032013000200032","volume":"50","author":"GS Florentino","year":"2013","unstructured":"G.S. Florentino, A. de, H.P. Cotrim, C.P. Vilar, A.V. Florentino, A. de, G.M.A. Guimaraes, V.S.T. Barreto, Nonalcoholic fatty liver disease in menopausal women. Arq. Gastroenterol. 50, 180\u2013185 (2013). https:\/\/doi.org\/10.1590\/S0004-28032013000200032","journal-title":"Arq. Gastroenterol."},{"key":"3878_CR104","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","volume":"65","author":"J McKenzie","year":"2006","unstructured":"J. McKenzie, B.M. Fisher, A.J. Jaap, A. Stanley, K. Paterson, N. Sattar, Effects of HRT on liver enzyme levels in women with type 2 diabetes: A randomized placebo-controlled trial. Clin. Endocrinol. (Oxf.) 65, 40\u201344 (2006). https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02543.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"3878_CR105","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/J.1365-2265.2008.03203.X","volume":"69","author":"O Koulouri","year":"2008","unstructured":"O. Koulouri, J. Ostberg, G.S. Conway, Liver dysfunction in Turner\u2019s syndrome: prevalence, natural history and effect of exogenous oestrogen. Clin. Endocrinol. (Oxf.) 69, 306\u2013310 (2008). https:\/\/doi.org\/10.1111\/J.1365-2265.2008.03203.X","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"3878_CR106","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/J.CGH.2016.07.034","volume":"15","author":"JD Yang","year":"2017","unstructured":"J.D. Yang, M.F. Abdelmalek, C. Guy, R. Gill, J.E. Lavine, K. Yates, J. Klair, et al., Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis. Clin. Gastroenterol. Hepatol. 15, 127\u2013131.e2 (2017). https:\/\/doi.org\/10.1016\/J.CGH.2016.07.034","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"3878_CR107","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/GME.0000000000000921","volume":"24","author":"JAV Pinkerton","year":"2017","unstructured":"J.A.V. Pinkerton, F.S. Aguirre, J. Blake, F. Cosman, H. Hodis, S. Hoffstetter, A.M. Kaunitz, S.A. Kingsberg, P.M. Maki, J.A.E. Manson, P. Marchbanks, M.R. McClung, L.E. Nachtigall, L.M. Nelson, D.T. Pace, R.L. Reid, P.M. Sarrel, J.L. Shifren, C.A. Stuenkel, W.H. Utian, The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 24, 728\u2013753 (2017). https:\/\/doi.org\/10.1097\/GME.0000000000000921","journal-title":"Menopause"},{"key":"3878_CR108","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/J.MOLMET.2013.12.009","volume":"3","author":"JH Kim","year":"2014","unstructured":"J.H. Kim, M.S. Meyers, S.S. Khuder, S.L. Abdallah, H.T. Muturi, L. Russo, C.R. Tate, A.L. Hevener, S.M. Najjar, C. Leloup, F. Mauvais-Jarvis, Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice. Mol. Metab. 3, 177\u2013190 (2014). https:\/\/doi.org\/10.1016\/J.MOLMET.2013.12.009","journal-title":"Mol. Metab."},{"key":"3878_CR109","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1152\/ajpendo.00653.2013.-Despite","volume":"307","author":"J Barrera","year":"2014","unstructured":"J. Barrera, K.L. Chambliss, M. Ahmed, K. Tanigaki, B. Thompson, J.G. McDonald, C. Mineo, P.W. Shaul, P.W. Shaul, Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract. Am. J. Physiol. Endocrinol. Metab. 307, 345\u2013354 (2014). https:\/\/doi.org\/10.1152\/ajpendo.00653.2013.-Despite","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"3878_CR110","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/13697137.2012.662251","volume":"16","author":"R Barsalani","year":"2013","unstructured":"R. Barsalani, E. Riesco, J.M. Lavoie, I.J. Dionne, Effect of exercise training and isoflavones on hepatic steatosis in overweight postmenopausal women. Climacteric 16, 88\u201395 (2013). https:\/\/doi.org\/10.3109\/13697137.2012.662251","journal-title":"Climacteric"},{"key":"3878_CR111","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/J.MATURITAS.2018.06.012","volume":"115","author":"M Glisic","year":"2018","unstructured":"M. Glisic, N. Kastrati, J. Musa, J. Milic, E. Asllanaj, E. Portilla Fernandez, J. Nano, C. Ochoa Rosales, M. Amiri, B. Kraja, A. Bano, W.M. Bramer, A.J.M. Roks, A.H.J. Danser, O.H. Franco, T. Muka, Phytoestrogen supplementation and body composition in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials. Maturitas 115, 74\u201383 (2018). https:\/\/doi.org\/10.1016\/J.MATURITAS.2018.06.012","journal-title":"Maturitas"},{"key":"3878_CR112","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/S11901-019-00495-9","volume":"18","author":"L Yuan","year":"2019","unstructured":"L. Yuan, A. Kardashian, M. Sarkar, NAFLD in women: Unique pathways, biomarkers and therapeutic opportunities. Curr. Hepatol. Rep. 18, 425\u2013432 (2019). https:\/\/doi.org\/10.1007\/S11901-019-00495-9","journal-title":"Curr. Hepatol. Rep."},{"key":"3878_CR113","doi-asserted-by":"publisher","unstructured":"Papadimitriou, K., Anagnostis, P., Goulis, D.G.: The challenging role of antiandrogens in the management of polycystic ovary syndrome. In: Polycystic Ovary Syndrome: Challenging Issues in the Modern Era of Individualized Medicine. pp. 297\u2013314. Elsevier (2022). https:\/\/doi.org\/10.1016\/B978-0-12-823045-9.00013-4","DOI":"10.1016\/B978-0-12-823045-9.00013-4"},{"key":"3878_CR114","doi-asserted-by":"publisher","unstructured":"Wada, T., Kenmochi, H., Miyashita, Y., Sasaki, M., Ojima, M., Sasahara, M., Koya, D., Tsuneki, H., Sasaoka, T.: Spironolactone Improves Glucose and Lipid Metabolism by Ameliorating Hepatic Steatosis and Inflammation and Suppressing Enhanced Gluconeogenesis Induced by High-Fat and High-Fructose Diet. 151, 2040\u20132049 (2010). https:\/\/doi.org\/10.1210\/en.2009-0869","DOI":"10.1210\/en.2009-0869"},{"key":"3878_CR115","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1111\/DOM.12989","volume":"19","author":"SA Polyzos","year":"2017","unstructured":"S.A. Polyzos, J. Kountouras, C.S. Mantzoros, V. Polymerou, P. Katsinelos, Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial. Diab. Obes. Metab. 19, 1805\u20131809 (2017). https:\/\/doi.org\/10.1111\/DOM.12989","journal-title":"Diab. Obes. Metab."},{"key":"3878_CR116","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/cells8101259","volume":"8","author":"C Lee","year":"2019","unstructured":"C. Lee, J. Kim, Y. Jung, Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease\/Nonalcoholic Steatohepatitis. Cells 8, 1259 (2019). https:\/\/doi.org\/10.3390\/cells8101259","journal-title":"Cells"},{"key":"3878_CR117","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3748\/WJG.V10.I9.1315","volume":"10","author":"QH Liu","year":"2004","unstructured":"Q.H. Liu, D.G. Li, X. Huang, C.H. Zong, Q.F. Xu, H.M. Lu, Suppressive effects of 17beta-estradiol on hepatic fibrosis in CCl4-induced rat model. World J. Gastroenterol. 10, 1315\u20131320 (2004). https:\/\/doi.org\/10.3748\/WJG.V10.I9.1315","journal-title":"World J. Gastroenterol."},{"key":"3878_CR118","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/J.JHEP.2015.11.004","volume":"64","author":"G Marchesini","year":"2016","unstructured":"G. Marchesini, C.P. Day, J.F. Dufour, A. Canbay, V. Nobili, V. Ratziu, H. Tilg, M. Roden, A. Gastaldelli, H. Yki-Jarvinen, F. Schick, R. Vettor, G. Fruhbeck, L. Mathus-Vliegen, EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 64, 1388\u20131402 (2016). https:\/\/doi.org\/10.1016\/J.JHEP.2015.11.004","journal-title":"J. Hepatol."},{"key":"3878_CR119","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s42000-021-00339-6","volume":"21","author":"I Vachliotis","year":"2022","unstructured":"I. Vachliotis, A. Goulas, P. Papaioannidou, S.A. Polyzos, Nonalcoholic fatty liver disease: lifestyle and quality of life. Hormones 21, 41\u201349 (2022). https:\/\/doi.org\/10.1007\/s42000-021-00339-6","journal-title":"Hormones"},{"key":"3878_CR120","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/IJO.2016.4","volume":"40","author":"J Otten","year":"2016","unstructured":"J. Otten, C. Mellberg, M. Ryberg, S. Sandberg, J. Kullberg, B. Lindahl, C. Larsson, J. Hauksson, T. Olsson, Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention. Int J. Obes. (Lond.) 40, 747\u2013753 (2016). https:\/\/doi.org\/10.1038\/IJO.2016.4","journal-title":"Int J. Obes. (Lond.)"},{"key":"3878_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-017-16159-X","volume":"7","author":"S Cheng","year":"2017","unstructured":"S. Cheng, J. Ge, C. Zhao, S. Le, Y. Yang, D. Ke, N. Wu, X. Tan, X. Zhang, X. Du, J. Sun, R. Wang, Y. Shi, R.J.H. Borra, R. Parkkola, P. Wiklund, D. Lu, Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: A randomized controlled trial. Sci. Rep. 7, 15952 (2017). https:\/\/doi.org\/10.1038\/S41598-017-16159-X","journal-title":"Sci. Rep."},{"key":"3878_CR122","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/OBR.12241","volume":"16","author":"RL Williams","year":"2015","unstructured":"R.L. Williams, L.G. Wood, C.E. Collins, R. Callister, Effectiveness of weight loss interventions\u2013is there a difference between men and women: a systematic review. Obes. Rev. 16, 171\u2013186 (2015). https:\/\/doi.org\/10.1111\/OBR.12241","journal-title":"Obes. Rev."},{"key":"3878_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/NU12092748","volume":"12","author":"M D\u2019abbondanza","year":"2020","unstructured":"M. D\u2019abbondanza, S. Ministrini, G. Pucci, E.N. Migliola, E.E. Martorelli, V. Gandolfo, D. Siepi, G. Lupattelli, G. Vaudo, Very Low-Carbohydrate Ketogenic Diet for the Treatment of Severe Obesity and Associated Non-Alcoholic Fatty Liver Disease: The Role of Sex Differences. Nutrients 12, 1\u201314 (2020). https:\/\/doi.org\/10.3390\/NU12092748","journal-title":"Nutrients"},{"key":"3878_CR124","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.3390\/NU15204468","volume":"15","author":"S De Nucci","year":"2023","unstructured":"S. De Nucci, C. Bonfiglio, R. Donvito, M. Di Chito, N. Cerabino, R. Rinaldi, A. Sila, E. Shahini, V. Giannuzzi, P.L. Pesole, S. Coletta, E. Lanzilotta, G. Piazzolla, R. Cozzolongo, G. Giannelli, G. De Pergola, Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity. Nutrients 15, 4468 (2023). https:\/\/doi.org\/10.3390\/NU15204468","journal-title":"Nutrients"},{"key":"3878_CR125","doi-asserted-by":"publisher","first-page":"154193","DOI":"10.1016\/J.METABOL.2020.154193","volume":"107","author":"G Mintziori","year":"2020","unstructured":"G. Mintziori, M.P. Nigdelis, H. Mathew, A. Mousiolis, D.G. Goulis, C.S. Mantzoros, The effect of excess body fat on female and male reproduction. Metabolism 107, 154193 (2020). https:\/\/doi.org\/10.1016\/J.METABOL.2020.154193","journal-title":"Metabolism"},{"key":"3878_CR126","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/0974-1208.69332","volume":"3","author":"S Pandey","year":"2010","unstructured":"S. Pandey, S. Pandey, A. Maheshwari, S. Bhattacharya, The impact of female obesity on the outcome of fertility treatment. J. Hum. Reprod. Sci. 3, 62\u201367 (2010). https:\/\/doi.org\/10.4103\/0974-1208.69332","journal-title":"J. Hum. Reprod. Sci."},{"key":"3878_CR127","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/NU9030204","volume":"9","author":"M McGrice","year":"2017","unstructured":"M. McGrice, J. Porter, The Effect of Low Carbohydrate Diets on Fertility Hormones and Outcomes in Overweight and Obese Women: A Systematic Review. Nutrients 9, 204 (2017). https:\/\/doi.org\/10.3390\/NU9030204","journal-title":"Nutrients"},{"key":"3878_CR128","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/S13679-023-00516-1","volume":"12","author":"E Camajani","year":"2023","unstructured":"E. Camajani, A. Feraco, L. Verde, E. Moriconi, M. Marchetti, A. Colao, M. Caprio, G. Muscogiuri, L. Barrea, Ketogenic Diet as a Possible Non-pharmacological Therapy in Main Endocrine Diseases of the Female Reproductive System: A Practical Guide for Nutritionists. Curr. Obes. Rep. 12, 231\u2013249 (2023). https:\/\/doi.org\/10.1007\/S13679-023-00516-1","journal-title":"Curr. Obes. Rep."},{"key":"3878_CR129","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/JOG.14650","volume":"47","author":"J Li","year":"2021","unstructured":"J. Li, W.P. Bai, B. Jiang, L.R. Bai, B. Gu, S.X. Yan, F.Y. Li, B. Huang, Ketogenic diet in women with polycystic ovary syndrome and liver dysfunction who are obese: A randomized, open-label, parallel-group, controlled pilot trial. J. Obstet. Gynaecol. Res 47, 1145\u20131152 (2021). https:\/\/doi.org\/10.1111\/JOG.14650","journal-title":"J. Obstet. Gynaecol. Res"},{"key":"3878_CR130","doi-asserted-by":"publisher","first-page":"12490","DOI":"10.3390\/IJERPH182312490","volume":"18","author":"RI Cincione","year":"2021","unstructured":"R.I. Cincione, F. Losavio, F. Ciolli, A. Valenzano, G. Cibelli, G. Messina, R. Polito, Effects of Mixed of a Ketogenic Diet in Overweight and Obese Women with Polycystic Ovary Syndrome. Int J. Environ. Res Public Health 18, 12490 (2021). https:\/\/doi.org\/10.3390\/IJERPH182312490","journal-title":"Int J. Environ. Res Public Health"},{"key":"3878_CR131","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1743-7075-2-35","volume":"2","author":"JC Mavropoulos","year":"2005","unstructured":"J.C. Mavropoulos, W.S. Yancy, J. Hepburn, E.C. Westman, The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study. Nutr. Metab. (Lond.) 2, 35 (2005). https:\/\/doi.org\/10.1186\/1743-7075-2-35","journal-title":"Nutr. Metab. (Lond.)"},{"key":"3878_CR132","doi-asserted-by":"publisher","first-page":"108420","DOI":"10.1016\/J.REPROTOX.2023.108420","volume":"119","author":"C Palafox-G\u00f3mez","year":"2023","unstructured":"C. Palafox-G\u00f3mez, G. Ortiz, I. Madrazo, E. L\u00f3pez-Bayghen, Adding a ketogenic dietary intervention to IVF treatment in patients with polycystic ovary syndrome improves implantation and pregnancy. Reprod. Toxicol. 119, 108420 (2023). https:\/\/doi.org\/10.1016\/J.REPROTOX.2023.108420","journal-title":"Reprod. Toxicol."},{"key":"3878_CR133","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"M.E. Rinella, B.A. Neuschwander-Tetri, M.S. Siddiqui, M.F. Abdelmalek, S. Caldwell, D. Barb, D.E. Kleiner, R. Loomba, AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77, 1797\u20131835 (2023). https:\/\/doi.org\/10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"key":"3878_CR134","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/S00508-021-01986-W","volume":"134","author":"DD Micic","year":"2022","unstructured":"D.D. Micic, H. Toplak, D.D. Micic, S.P. Polovina, Reproductive outcomes after bariatric surgery in women. Wien. Klin. Wochenschr. 134, 56\u201362 (2022). https:\/\/doi.org\/10.1007\/S00508-021-01986-W","journal-title":"Wien. Klin. Wochenschr."},{"key":"3878_CR135","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/J.SOARD.2021.05.003","volume":"17","author":"MR Emami","year":"2021","unstructured":"M.R. Emami, M. Safabakhsh, M. Khorshidi, O. Moradi Moghaddam, S.H. Mohammed, M. Zarezadeh, S. Alizadeh, Effect of bariatric surgery on endogenous sex hormones and sex hormone-binding globulin levels: a systematic review and meta-analysis. Surg. Obes. Relat. Dis. 17, 1621\u20131636 (2021). https:\/\/doi.org\/10.1016\/J.SOARD.2021.05.003","journal-title":"Surg. Obes. Relat. Dis."},{"key":"3878_CR136","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/J.RBMS.2021.09.002","volume":"14","author":"R Westerman","year":"2021","unstructured":"R. Westerman, A.K. Kuhnt, Metabolic risk factors and fertility disorders: A narrative review of the female perspective. Reprod. Biomed. Soc. Online 14, 66\u201374 (2021). https:\/\/doi.org\/10.1016\/J.RBMS.2021.09.002","journal-title":"Reprod. Biomed. Soc. Online"},{"key":"3878_CR137","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/J.FERTNSTERT.2005.12.041","volume":"86","author":"V Tsagareli","year":"2006","unstructured":"V. Tsagareli, M. Noakes, R.J. Norman, Effect of a very-low-calorie diet on in vitro fertilization outcomes. Fertil. Steril. 86, 227\u2013229 (2006). https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2005.12.041","journal-title":"Fertil. Steril."},{"key":"3878_CR138","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/MODPATHOL.2017.13","volume":"30","author":"JH Tsai","year":"2017","unstructured":"J.H. Tsai, L.D. Ferrell, V. Tan, M.M. Yeh, M. Sarkar, R.M. Gill, Aggressive non-alcoholic steatohepatitis following rapid weight loss and\/or malnutrition. Mod. Pathol. 30, 834\u2013842 (2017). https:\/\/doi.org\/10.1038\/MODPATHOL.2017.13","journal-title":"Mod. Pathol."},{"key":"3878_CR139","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/J.METABOL.2016.05.013","volume":"65","author":"SA Polyzos","year":"2016","unstructured":"S.A. Polyzos, C.S. Mantzoros, Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review. Metabolism 65, 1297\u20131306 (2016). https:\/\/doi.org\/10.1016\/J.METABOL.2016.05.013","journal-title":"Metabolism"},{"key":"3878_CR140","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/S12905-021-01448-5","volume":"21","author":"M Amirian","year":"2021","unstructured":"M. Amirian, S. Shariat Moghani, F. Jafarian, M. Mirteimouri, S. Nikdoust, S. Niroumand, M. Salehi, A. Payrovnaziri, Combination of pioglitazone and clomiphene citrate versus clomiphene citrate alone for infertile women with the polycystic ovarian syndrome. BMC Women\u2019s Health 21, 302 (2021). https:\/\/doi.org\/10.1186\/S12905-021-01448-5","journal-title":"BMC Women\u2019s Health"},{"key":"3878_CR141","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/S13224-012-0183-3","volume":"62","author":"S Sangeeta","year":"2012","unstructured":"S. Sangeeta, Metformin and pioglitazone in polycystic ovarian syndrome: a comparative study. J. Obstet. Gynaecol. India 62, 551\u2013556 (2012). https:\/\/doi.org\/10.1007\/S13224-012-0183-3","journal-title":"J. Obstet. Gynaecol. India"},{"key":"3878_CR142","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/J.FERTNSTERT.2007.01.117","volume":"90","author":"H Ota","year":"2008","unstructured":"H. Ota, T. Goto, T. Yoshioka, N. Ohyama, Successful pregnancies treated with pioglitazone in infertile patients with polycystic ovary syndrome. Fertil. Steril. 90, 709\u2013713 (2008). https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2007.01.117","journal-title":"Fertil. Steril."},{"key":"3878_CR143","doi-asserted-by":"publisher","first-page":"154203","DOI":"10.1016\/J.METABOL.2020.154203","volume":"111S","author":"SA Polyzos","year":"2020","unstructured":"S.A. Polyzos, E.S. Kang, C. Boutari, E.J. Rhee, C.S. Mantzoros, Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis. Metabolism 111S, 154203 (2020). https:\/\/doi.org\/10.1016\/J.METABOL.2020.154203","journal-title":"Metabolism"},{"key":"3878_CR144","doi-asserted-by":"publisher","unstructured":"A. Gastaldelli, K. Cusi, L. Fern\u00e1ndez Land\u00f3, R. Bray, B. Brouwers, \u00c1. Rodr\u00edguez, Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial. Lancet Diab. Endocrinol. 10, 393\u2013406 (2022). https:\/\/doi.org\/10.1016\/S2213-8587(22)00070-5","DOI":"10.1016\/S2213-8587(22)00070-5"},{"key":"3878_CR145","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMOA2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"A.M. Jastreboff, L.J. Aronne, N.N. Ahmad, S. Wharton, L. Connery, B. Alves, A. Kiyosue, S. Zhang, B. Liu, M.C. Bunck, A. Stefanski, Tirzepatide Once Weekly for the Treatment of Obesity. N. Engl. J. Med 387, 205\u2013216 (2022). https:\/\/doi.org\/10.1056\/NEJMOA2206038","journal-title":"N. Engl. J. Med"},{"key":"3878_CR146","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.2174\/0929867330666230106103202","volume":"30","author":"SA Polyzos","year":"2023","unstructured":"S.A. Polyzos, A. Goulas, P. Papaioannidou, Tirzepatide for Diabetes and Obesity: A New Window to the Treatment of Non-alcoholic Steatohepatitis. Curr. Med. Chem. 30, 2476\u20132479 (2023). https:\/\/doi.org\/10.2174\/0929867330666230106103202","journal-title":"Curr. Med. Chem."},{"key":"3878_CR147","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/HUMUPD\/DMZ019","volume":"25","author":"M Jensterle","year":"2019","unstructured":"M. Jensterle, A. Janez, E. Fliers, J.H. Devries, E. Vrtacnik-Bokal, S.E. Siegelaar, The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective. Hum. Reprod. Update 25, 504\u2013517 (2019). https:\/\/doi.org\/10.1093\/HUMUPD\/DMZ019","journal-title":"Hum. Reprod. Update"},{"key":"3878_CR148","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.17219\/ACEM\/151695","volume":"31","author":"GS Papaetis","year":"2022","unstructured":"G.S. Papaetis, A. Kyriacou, GLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: Current research and future horizons. Adv. Clin. Exp. Med. 31, 1265\u20131274 (2022). https:\/\/doi.org\/10.17219\/ACEM\/151695","journal-title":"Adv. Clin. Exp. Med."},{"key":"3878_CR149","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/S11154-021-09687-5","volume":"23","author":"C Pic\u00f3","year":"2022","unstructured":"C. Pic\u00f3, M. Palou, C.A. Pomar, A.M. Rodr\u00edguez, A. Palou, Leptin as a key regulator of the adipose organ. Rev. Endocr. Metab. Disord. 23, 13\u201330 (2022). https:\/\/doi.org\/10.1007\/S11154-021-09687-5","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"3878_CR150","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1210\/ER.2012-1053","volume":"34","author":"HS Moon","year":"2013","unstructured":"H.S. Moon, M. Dalamaga, S.Y. Kim, S.A. Polyzos, O.P. Hamnvik, F. Magkos, J. Paruthi, C.S. Mantzoros, Leptin\u2019s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr. Rev. 34, 377\u2013412 (2013). https:\/\/doi.org\/10.1210\/ER.2012-1053","journal-title":"Endocr. Rev."},{"key":"3878_CR151","doi-asserted-by":"publisher","first-page":"154229","DOI":"10.1016\/j.metabol.2020.154229","volume":"107","author":"C Boutari","year":"2020","unstructured":"C. Boutari, P.D. Pappas, G. Mintziori, M.P. Nigdelis, L. Athanasiadis, D.G. Goulis, C.S. Mantzoros, The effect of underweight on female and male reproduction. Metabolism 107, 154229 (2020). https:\/\/doi.org\/10.1016\/j.metabol.2020.154229","journal-title":"Metabolism"},{"key":"3878_CR152","doi-asserted-by":"publisher","first-page":"6585","DOI":"10.1073\/PNAS.1015674108","volume":"108","author":"SH Chou","year":"2011","unstructured":"S.H. Chou, J.P. Chamberland, X. Liu, G. Matarese, C. Gao, R. Stefanakis, M.T. Brinkoetter, H. Gong, K. Arampatzi, C.S. Mantzoros, Leptin is an effective treatment for hypothalamic amenorrhea. Proc. Natl Acad. Sci. USA 108, 6585\u20136590 (2011). https:\/\/doi.org\/10.1073\/PNAS.1015674108","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3878_CR153","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/S42255-019-0095-Y","volume":"1","author":"JM Friedman","year":"2019","unstructured":"J.M. Friedman, Leptin and the endocrine control of energy balance. Nat. Metab. 1, 754\u2013764 (2019). https:\/\/doi.org\/10.1038\/S42255-019-0095-Y","journal-title":"Nat. Metab."},{"key":"3878_CR154","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/MCG.0000000000000925","volume":"52","author":"I Doycheva","year":"2018","unstructured":"I. Doycheva, D. Issa, K.D. Watt, R. Lopez, G. Rifai, N. Alkhouri, Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States. J. Clin. Gastroenterol. 52, 339\u2013346 (2018). https:\/\/doi.org\/10.1097\/MCG.0000000000000925","journal-title":"J. Clin. Gastroenterol."},{"key":"3878_CR155","doi-asserted-by":"publisher","first-page":"491","DOI":"10.14309\/AJG.0000000000001105","volume":"116","author":"N Valentin","year":"2021","unstructured":"N. Valentin, I. Guerrido, F. Rozenshteyn, R. Pinotti, Y.C. Wu, K. Collins, M. Shah, M. Hershman, I. Weisberg, Pregnancy Outcomes After Liver Transplantation: A Systematic Review and Meta-Analysis. Am. J. Gastroenterol. 116, 491\u2013504 (2021). https:\/\/doi.org\/10.14309\/AJG.0000000000001105","journal-title":"Am. J. Gastroenterol."},{"key":"3878_CR156","doi-asserted-by":"publisher","first-page":"1184530","DOI":"10.3389\/FENDO.2023.1184530","volume":"14","author":"M Spaziani","year":"2023","unstructured":"M. Spaziani, F. Carlomagno, C. Tarantino, F. Angelini, L. Vincenzi, D. Gianfrilli, New perspectives in functional hypogonadotropic hypogonadism: beyond late onset hypogonadism. Front. Endocrinol. (Lausanne) 14, 1184530 (2023). https:\/\/doi.org\/10.3389\/FENDO.2023.1184530","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"3878_CR157","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-230X-12-69","volume":"12","author":"S Kim","year":"2012","unstructured":"S. Kim, H. Kwon, J.H. Park, B. Cho, D. Kim, S.W. Oh, C.M. Lee, H.C. Choi, A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterol. 12, 69 (2012). https:\/\/doi.org\/10.1186\/1471-230X-12-69","journal-title":"BMC Gastroenterol."},{"key":"3878_CR158","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1179\/2045772314Y.0000000288","volume":"39","author":"A Barbonetti","year":"2016","unstructured":"A. Barbonetti, M. Rosaria, C. Vassallo, M. Cotugno, G. Felzani, S. Francavilla, F. Francavilla, Low testosterone and non-alcoholic fatty liver disease: Evidence for their independent association in men with chronic spinal cord injury. J. Spinal Cord. Med. 39, 443\u2013449 (2016). https:\/\/doi.org\/10.1179\/2045772314Y.0000000288","journal-title":"J. Spinal Cord. Med."},{"key":"3878_CR159","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/XCE.0000000000000057","volume":"4","author":"A Mody","year":"2015","unstructured":"A. Mody, D. Whitec, F. Kanwal, J.M. Garcia, Relevance of low testosterone to non-alcoholic fatty liver disease. Cardiovasc. Endocrinol. 4, 83\u201389 (2015). https:\/\/doi.org\/10.1097\/XCE.0000000000000057","journal-title":"Cardiovasc. Endocrinol."},{"key":"3878_CR160","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1210\/JC.2005-1326","volume":"91","author":"V Kupelian","year":"2006","unstructured":"V. Kupelian, S.T. Page, A.B. Araujo, T.G. Travison, W.J. Bremner, J.B. McKinlay, Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J. Clin. Endocrinol. Metab. 91, 843\u2013850 (2006). https:\/\/doi.org\/10.1210\/JC.2005-1326","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3878_CR161","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/S12020-015-0563-4","volume":"50","author":"M Bekaert","year":"2015","unstructured":"M. Bekaert, Y. Van Nieuwenhove, P. Calders, C.A. Cuvelier, A.H. Batens, J.M. Kaufman, D.M. Ouwens, J.B. Ruige, Determinants of testosterone levels in human male obesity. Endocrine 50, 202\u2013211 (2015). https:\/\/doi.org\/10.1007\/S12020-015-0563-4","journal-title":"Endocrine"},{"key":"3878_CR162","doi-asserted-by":"publisher","first-page":"e522","DOI":"10.1210\/CLINEM\/DGAD586","volume":"109","author":"N Caretta","year":"2024","unstructured":"N. Caretta, R. Scafa, A. Graziani, M.C. Crepaldi, M. Vedovato, A. Avogaro, A. Ferlin, Noninvasive Indices of MASLD Are Associated With Hypogonadism in Male Patients With Type 2 Diabetes Mellitus. J. Clin. Endocrinol. Metab. 109, e522\u2013e530 (2024). https:\/\/doi.org\/10.1210\/CLINEM\/DGAD586","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3878_CR163","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/J.1467-789X.2011.00978.X","volume":"13","author":"GX Tian","year":"2012","unstructured":"G.X. Tian, Y. Sun, C.J. Pang, A.H. Tan, Y. Gao, H.Y. Zhang, X.B. Yang, Z.X. Li, Z.N. Mo, Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men. Obes. Rev. 13, 381\u2013387 (2012). https:\/\/doi.org\/10.1111\/J.1467-789X.2011.00978.X","journal-title":"Obes. Rev."},{"key":"3878_CR164","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4103\/AJA.AJA_68_19","volume":"22","author":"F Van De Velde","year":"2020","unstructured":"F. Van De Velde, M. Bekaert, A. Hoorens, A. Geerts, G. T\u2019Sjoen, T. Fiers, J.M. Kaufman, Y. Van Nieuwenhove, B. Lapauw, Histologically proven hepatic steatosis associates with lower testosterone levels in men with obesity. Asian J. Androl. 22, 252\u2013257 (2020). https:\/\/doi.org\/10.4103\/AJA.AJA_68_19","journal-title":"Asian J. Androl."},{"key":"3878_CR165","doi-asserted-by":"publisher","first-page":"758","DOI":"10.14309\/ajg.0000000000000138","volume":"114","author":"M Sarkar","year":"2019","unstructured":"M. Sarkar, L.B. VanWagner, J.G. Terry, J.J. Carr, M. Rinella, P.J. Schreiner, C.E. Lewis, N. Terrault, Coronary Artery Risk Development in Young Adults (CARDIA) Cohort.: Sex hormone\u2013binding globulin levels in young men are associated with nonalcoholic fatty liver disease in midlife. Am. J. Gastroenterol. 114, 758\u2013763 (2019). https:\/\/doi.org\/10.14309\/ajg.0000000000000138","journal-title":"Am. J. Gastroenterol."},{"key":"3878_CR166","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/J.METABOL.2012.08.012","volume":"62","author":"K Michalakis","year":"2013","unstructured":"K. Michalakis, G. Mintziori, A. Kaprara, B.C. Tarlatzis, D.G. Goulis, The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review. Metabolism 62, 457\u2013478 (2013). https:\/\/doi.org\/10.1016\/J.METABOL.2012.08.012","journal-title":"Metabolism"},{"key":"3878_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/S40842-020-00106-3","volume":"6","author":"SJ Winters","year":"2020","unstructured":"S.J. Winters, SHBG and total testosterone levels in men with adult onset hypogonadism: what are we overlooking? Clin. Diab Endocrinol. 6, 17 (2020). https:\/\/doi.org\/10.1186\/S40842-020-00106-3","journal-title":"Clin. Diab Endocrinol."},{"key":"3878_CR168","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/09513590.2017.1411474","volume":"34","author":"C Feng","year":"2018","unstructured":"C. Feng, Z. Jin, X. Chi, B. Zhang, X. Wang, L. Sun, J. Fan, Q. Sun, X. Zhang, SHBG expression is correlated with PI3K\/AKT pathway activity in a cellular model of human insulin resistance. Gynecol. Endocrinol. 34, 567\u2013573 (2018). https:\/\/doi.org\/10.1080\/09513590.2017.1411474","journal-title":"Gynecol. Endocrinol."},{"key":"3878_CR169","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1530\/EC-20-0401","volume":"9","author":"SJ Winters","year":"2020","unstructured":"S.J. Winters, C.R. Scoggins, D. Appiah, D.T. Ghooray, The hepatic lipidome and HNF4\u03b1 and SHBG expression in human liver. Endocr. Connect. 9, 1009\u20131018 (2020). https:\/\/doi.org\/10.1530\/EC-20-0401","journal-title":"Endocr. Connect."},{"key":"3878_CR170","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1530\/EJE-08-0266","volume":"159","author":"RD Stanworth","year":"2008","unstructured":"R.D. Stanworth, D. Kapoor, K.S. Channer, T.H. Jones, Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes. Eur. J. Endocrinol. 159, 739\u2013746 (2008). https:\/\/doi.org\/10.1530\/EJE-08-0266","journal-title":"Eur. J. Endocrinol."},{"key":"3878_CR171","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/J.STEROIDS.2018.04.004","volume":"135","author":"HF Sakr","year":"2018","unstructured":"H.F. Sakr, A.M. Hussein, E.A. Eid, M. AlKhateeb, Possible mechanisms underlying fatty liver in a rat model of male hypogonadism: A protective role for testosterone. Steroids 135, 21\u201330 (2018). https:\/\/doi.org\/10.1016\/J.STEROIDS.2018.04.004","journal-title":"Steroids"},{"key":"3878_CR172","doi-asserted-by":"publisher","unstructured":"S. Mov\u00e9rare-Skrtic, K. Venken, N. Andersson, M.K. Lindberg, J. Svensson, C. Swanson, D. Vanderschueren, J. Oscarsson, J.\u00c5. Gustafsson, C. Ohlsson, Dihydrotestosterone Treatment Results in Obesity and Altered Lipid Metabolism in Orchidectomized Mice. Obesity 14, 662\u2013672 (2006). https:\/\/doi.org\/10.1038\/OBY.2006.75","DOI":"10.1038\/OBY.2006.75"},{"key":"3878_CR173","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1530\/EJE.0.1510415","volume":"151","author":"F Schleich","year":"2004","unstructured":"F. Schleich, J.J. Legros, Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male. Eur. J. Endocrinol. 151, 415\u2013424 (2004). https:\/\/doi.org\/10.1530\/EJE.0.1510415","journal-title":"Eur. J. Endocrinol."},{"key":"3878_CR174","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S0006-291X(02)02038-7","volume":"296","author":"C Langer","year":"2002","unstructured":"C. Langer, B. Gansz, C. Goepfert, T. Engel, Y. Uehara, G. Von Dehn, H. Jansen, G. Assmann, A. Von Eckardstein, Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages. Biochem. Biophys. Res. Commun. 296, 1051\u20131057 (2002). https:\/\/doi.org\/10.1016\/S0006-291X(02)02038-7","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"3878_CR175","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/J.DSX.2020.07.049","volume":"14","author":"SA Polyzos","year":"2020","unstructured":"S.A. Polyzos, A. Mousiolis, G. Mintziori, D.G. Goulis, Nonalcoholic fatty liver disease in males with low testosterone concentrations. Diab Metab. Syndrome: Clin. Res. Rev. 14, 1571\u20131577 (2020). https:\/\/doi.org\/10.1016\/J.DSX.2020.07.049","journal-title":"Diab Metab. Syndrome: Clin. Res. Rev."},{"key":"3878_CR176","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1530\/EJE-17-0071","volume":"177","author":"LV Magnussen","year":"2017","unstructured":"L.V. Magnussen, P.E. Andersen, A. Diaz, J. Ostojic, K. H\u00f8jlund, D.M. Hougaard, A.N. Christensen, T.L. Nielsen, M. Andersen, MR spectroscopy of hepatic fat and adiponectin and leptin levels during testosterone therapy in type 2 diabetes: a randomized, double-blinded, placebo-controlled trial. Eur. J. Endocrinol. 177, 157\u2013168 (2017). https:\/\/doi.org\/10.1530\/EJE-17-0071","journal-title":"Eur. J. Endocrinol."},{"key":"3878_CR177","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1530\/EJE-12-0525","volume":"167","author":"CM Hoyos","year":"2012","unstructured":"C.M. Hoyos, B.J. Yee, C.L. Phillips, E.A. Machan, R.R. Grunstein, P.Y. Liu, Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial. Eur. J. Endocrinol. 167, 531\u2013541 (2012). https:\/\/doi.org\/10.1530\/EJE-12-0525","journal-title":"Eur. J. Endocrinol."},{"key":"3878_CR178","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/HEP4.1571","volume":"4","author":"S Albhaisi","year":"2020","unstructured":"S. Albhaisi, K. Kim, J. Baker, N. Chidambaram, M.V. Patel, M. Charlton, A.J. Sanyal, LPCN 1144 Resolves NAFLD in Hypogonadal Males. Hepatol. Commun. 4, 1430\u20131440 (2020). https:\/\/doi.org\/10.1002\/HEP4.1571","journal-title":"Hepatol. Commun."},{"key":"3878_CR179","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4254\/WJH.V14.I4.754","volume":"14","author":"R Apostolov","year":"2022","unstructured":"R. Apostolov, E. Gianatti, D. Wong, N. Kutaiba, P. Gow, M. Grossmann, M. Sinclair, Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations. World J. Hepatol. 14, 754\u2013765 (2022). https:\/\/doi.org\/10.4254\/WJH.V14.I4.754","journal-title":"World J. Hepatol."},{"key":"3878_CR180","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/2090598X.2021.1959261","volume":"19","author":"A Al-Qudimat","year":"2021","unstructured":"A. Al-Qudimat, R.M. Al-Zoubi, A.A. Yassin, M. Alwani, O.M. Aboumarzouk, K. AlRumaihi, R. Talib, A. Al Ansari, Testosterone treatment improves liver function and reduces cardiovascular risk: A long-term prospective study. Arab J. Urol. 19, 376\u2013386 (2021). https:\/\/doi.org\/10.1080\/2090598X.2021.1959261","journal-title":"Arab J. Urol."},{"key":"3878_CR181","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/S41366-019-0517-7","volume":"44","author":"F Saad","year":"2020","unstructured":"F. Saad, G. Doros, K.S. Haider, A. Haider, Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from a controlled registry study. Int. J. Obes. (Lond.) 44, 1264\u20131278 (2020). https:\/\/doi.org\/10.1038\/S41366-019-0517-7","journal-title":"Int. J. Obes. (Lond.)"},{"key":"3878_CR182","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1080\/13685538.2020.1867094","volume":"23","author":"AA Yassin","year":"2020","unstructured":"A.A. Yassin, M. Alwani, R. Talib, Y. Almehmadi, J.E. Nettleship, K. Alrumaihi, B. Albaba, D.M. Kelly, F. Saad, Long-term testosterone therapy improves liver parameters and steatosis in hypogonadal men: a prospective controlled registry study. Aging Male 23, 1553\u20131563 (2020). https:\/\/doi.org\/10.1080\/13685538.2020.1867094","journal-title":"Aging Male"},{"key":"3878_CR183","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/S40618-020-01381-8","volume":"44","author":"E Maseroli","year":"2021","unstructured":"E. Maseroli, P. Comeglio, C. Corno, I. Cellai, S. Filippi, T. Mello, A. Galli, E. Rapizzi, L. Presenti, M.C. Truglia, F. Lotti, E. Facchiano, B. Beltrame, M. Lucchese, F. Saad, G. Rastrelli, M. Maggi, L. Vignozzi, Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men. J. Endocrinol. Invest 44, 819\u2013842 (2021). https:\/\/doi.org\/10.1007\/S40618-020-01381-8","journal-title":"J. Endocrinol. Invest"},{"key":"3878_CR184","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/gerona\/gls259","volume":"68","author":"G Huang","year":"2013","unstructured":"G. Huang, S. Bhasin, E.R. Tang, A. Aakil, S.W. Anderson, H. Jara, M. Davda, T.G. Travison, S. Basaria, Effect of Testosterone Administration on Liver Fat in Older Men With Mobility Limitation: Results From a Randomized Controlled Trial. Med. Sci. Cite J.: J. Gerontol. A Biol. Sci. Med. Sci. 68, 954\u2013959 (2013). https:\/\/doi.org\/10.1093\/gerona\/gls259","journal-title":"Med. Sci. Cite J.: J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"3878_CR185","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/AJA.2011.138","volume":"14","author":"G Corona","year":"2012","unstructured":"G. Corona, G. Rastrelli, L. Vignozzi, E. Mannucci, M. Maggi, How to recognize late-onset hypogonadism in men with sexual dysfunction. Asian J. Androl. 14, 251\u2013259 (2012). https:\/\/doi.org\/10.1038\/AJA.2011.138","journal-title":"Asian J. Androl."},{"key":"3878_CR186","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/J.BEEM.2013.05.002","volume":"27","author":"G Corona","year":"2013","unstructured":"G. Corona, G. Rastrelli, M. Maggi, Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes. Best. Pract. Res. Clin. Endocrinol. Metab. 27, 557\u2013579 (2013). https:\/\/doi.org\/10.1016\/J.BEEM.2013.05.002","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"3878_CR187","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/S00535-017-1415-1","volume":"53","author":"Y Sumida","year":"2018","unstructured":"Y. Sumida, M. Yoneda, Current and future pharmacological therapies for NAFLD\/NASH. J. Gastroenterol. 53, 362\u2013376 (2018). https:\/\/doi.org\/10.1007\/S00535-017-1415-1","journal-title":"J. Gastroenterol."},{"key":"3878_CR188","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/HEP.23276","volume":"51","author":"K Promrat","year":"2010","unstructured":"K. Promrat, D.E. Kleiner, H.M. Niemeier, E. Jackvony, M. Kearns, J.R. Wands, J.L. Fava, R.R. Wing, Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51, 121\u2013129 (2010). https:\/\/doi.org\/10.1002\/HEP.23276","journal-title":"Hepatology"},{"key":"3878_CR189","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.2337\/DC18-0071","volume":"41","author":"PK Luukkonen","year":"2018","unstructured":"P.K. Luukkonen, S. S\u00e4devirta, Y. Zhou, B. Kayser, A. Ali, L. Ahonen, S. Lallukka, V. Pelloux, M. Gaggini, C. Jian, A. Hakkarainen, N. Lundbom, H. Gylling, A. Salonen, M. Oresic, T. Hy\u00f6tyl\u00e4inen, M. Orho-Melander, A. Rissanen, A. Gastaldelli, K. Cl\u00e9ment, L. Hodson, H. Yki-J\u00e4rvinen, Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars. Diab. Care 41, 1732\u20131739 (2018). https:\/\/doi.org\/10.2337\/DC18-0071","journal-title":"Diab. Care"},{"key":"3878_CR190","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/J.CLNU.2022.06.037","volume":"41","author":"L Haigh","year":"2022","unstructured":"L. Haigh, C. Kirk, K. El Gendy, J. Gallacher, L. Errington, J.C. Mathers, Q.M. Anstee, The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis. Clin. Nutr. 41, 1913\u20131931 (2022). https:\/\/doi.org\/10.1016\/J.CLNU.2022.06.037","journal-title":"Clin. Nutr."},{"key":"3878_CR191","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.3390\/IJERPH16173011","volume":"16","author":"L Abenavoli","year":"2019","unstructured":"L. Abenavoli, L. Boccuto, A. Federico, M. Dallio, C. Loguercio, L. Di Renzo, A. De Lorenzo, Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. Int. J. Environ. Res. Public Health 16, 3011 (2019). https:\/\/doi.org\/10.3390\/IJERPH16173011","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"3878_CR192","doi-asserted-by":"publisher","unstructured":"S. Montemayor, C.M. Mascar\u00f3, L. Ugarriza, M. Casares, I. Llompart, I. Abete, M.\u00c1. Zulet, J.A. Mart\u00ednez, J.A. Tur, C. Bouzas, Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study. Nutrients 14, 3186 (2022). https:\/\/doi.org\/10.3390\/NU14153186","DOI":"10.3390\/NU14153186"},{"key":"3878_CR193","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1530\/EJE-12-0955","volume":"168","author":"G Corona","year":"2013","unstructured":"G. Corona, G. Rastrelli, M. Monami, F. Saad, M. Luconi, M. Lucchese, E. Facchiano, A. Sforza, G. Forti, E. Mannucci, M. Maggi, Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur. J. Endocrinol. 168, 829\u2013843 (2013). https:\/\/doi.org\/10.1530\/EJE-12-0955","journal-title":"Eur. J. Endocrinol."},{"key":"3878_CR194","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/NU10040474","volume":"10","author":"A de Lorenzo","year":"2018","unstructured":"A. de Lorenzo, A. Noce, E. Moriconi, T. Rampello, G. Marrone, N. di Daniele, V. Rovella, MOSH Syndrome (Male Obesity Secondary Hypogonadism): Clinical Assessment and Possible Therapeutic Approaches. Nutrients 10, 474 (2018). https:\/\/doi.org\/10.3390\/NU10040474","journal-title":"Nutrients"},{"key":"3878_CR195","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.3390\/JCM11175126","volume":"11","author":"I Mi\u00f1ambres","year":"2022","unstructured":"I. Mi\u00f1ambres, H. Sard\u00e0, E. Urgell, I. Genua, A. Ramos, S. Fern\u00e1ndez-Ananin, C. Balagu\u00e9, J.L. S\u00e1nchez-Quesada, L. Bassas, A. P\u00e9rez, Obesity Surgery Improves Hypogonadism and Sexual Function in Men without Effects in Sperm Quality. J. Clin. Med. 11, 5126 (2022). https:\/\/doi.org\/10.3390\/JCM11175126","journal-title":"J. Clin. Med."},{"key":"3878_CR196","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/HUMUPD\/DMX012","volume":"23","author":"HF Escobar-Morreale","year":"2017","unstructured":"H.F. Escobar-Morreale, E. Santacruz, M. Luque-Ram\u00edrez, J.I.B. Carretero, Prevalence of \u201cobesity-associated gonadal dysfunction\u201d in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis. Hum. Reprod. Update 23, 390\u2013408 (2017). https:\/\/doi.org\/10.1093\/HUMUPD\/DMX012","journal-title":"Hum. Reprod. Update"},{"key":"3878_CR197","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3760\/cma.j.cn441530-20220429-00190","volume":"25","author":"SJ Luo","year":"2022","unstructured":"S.J. Luo, J.X. Zheng, Y.T. Chen, Z.W. Xie, Z.S. Yang, G.J. Chen, C.C. Wang, Z.Y. Dong, Effects of bariatric surgery on sex hormones in male patients with obesity. Zhonghua Wei Chang Wai Ke Za Zhi 25, 921\u2013927 (2022). https:\/\/doi.org\/10.3760\/cma.j.cn441530-20220429-00190","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"3878_CR198","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/S11695-012-0734-9","volume":"22","author":"S Pellitero","year":"2012","unstructured":"S. Pellitero, I. Olaizola, A. Alastrue, E. Mart\u00ednez, M.L. Granada, J.M. Balibrea, P. Moreno, A. Serra, M. Navarro-D\u00edaz, R. Romero, M. Puig-Domingo, Hypogonadotropic hypogonadism in morbidly obese males is reversed after bariatric surgery. Obes. Surg. 22, 1835\u20131842 (2012). https:\/\/doi.org\/10.1007\/S11695-012-0734-9","journal-title":"Obes. Surg."},{"key":"3878_CR199","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/CEN.13723","volume":"89","author":"M Grossmann","year":"2018","unstructured":"M. Grossmann, Hypogonadism and male obesity: Focus on unresolved questions. Clin. Endocrinol. (Oxf.) 89, 11\u201321 (2018). https:\/\/doi.org\/10.1111\/CEN.13723","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"3878_CR200","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/J.CGH.2008.08.012","volume":"6","author":"RR Mummadi","year":"2008","unstructured":"R.R. Mummadi, K.S. Kasturi, S. Chennareddygari, G.K. Sood, Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 6, 1396\u20131402 (2008). https:\/\/doi.org\/10.1016\/J.CGH.2008.08.012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"3878_CR201","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/J.1572-0241.2005.41583.X","volume":"100","author":"E Bugianesi","year":"2005","unstructured":"E. Bugianesi, E. Gentilcore, R. Manini, S. Natale, E. Vanni, N. Villanova, E. David, M. Rizzetto, G. Marchesini, A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am. J. Gastroenterol. 100, 1082\u20131090 (2005). https:\/\/doi.org\/10.1111\/J.1572-0241.2005.41583.X","journal-title":"Am. J. Gastroenterol."},{"key":"3878_CR202","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/S00125-011-2446-4","volume":"55","author":"G Musso","year":"2012","unstructured":"G. Musso, M. Cassader, F. Rosina, R. Gambino, Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 55, 885\u2013904 (2012). https:\/\/doi.org\/10.1007\/S00125-011-2446-4","journal-title":"Diabetologia"},{"key":"3878_CR203","doi-asserted-by":"publisher","first-page":"305","DOI":"10.7326\/M15-1774","volume":"165","author":"K Cusi","year":"2016","unstructured":"K. Cusi, B. Orsak, F. Bril, R. Lomonaco, J. Hecht, C. Ortiz-Lopez, F. Tio, J. Hardies, C. Darland, N. Musi, A. Webb, P. Portillo-Sanchez, Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial. Ann. Intern. Med. 165, 305\u2013315 (2016). https:\/\/doi.org\/10.7326\/M15-1774","journal-title":"Ann. Intern. Med."},{"key":"3878_CR204","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2337\/DC19-0167","volume":"42","author":"F Bril","year":"2019","unstructured":"F. Bril, D.M. Biernacki, S. Kalavalapalli, R. Lomonaco, S.K. Subbarayan, J. Lai, F. Tio, A. Suman, B.K. Orsak, J. Hecht, K. Cusi, Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial. Diab. Care 42, 1481\u20131488 (2019). https:\/\/doi.org\/10.2337\/DC19-0167","journal-title":"Diab. Care"},{"key":"3878_CR205","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMOA060326","volume":"355","author":"R Belfort","year":"2006","unstructured":"R. Belfort, S.A. Harrison, K. Brown, C. Darland, J. Finch, J. Hardies, B. Balas, A. Gastaldelli, F. Tio, J. Pulcini, R. Berria, J.Z. Ma, S. Dwivedi, R. Havranek, C. Fincke, R. DeFronzo, G.A. Bannayan, S. Schenker, K. Cusi, A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355, 2297\u20132307 (2006). https:\/\/doi.org\/10.1056\/NEJMOA060326","journal-title":"N. Engl. J. Med."},{"key":"3878_CR206","doi-asserted-by":"publisher","first-page":"22","DOI":"10.18433\/J3TG6H","volume":"11","author":"B Gholamine","year":"2008","unstructured":"B. Gholamine, M. Shafiei, M. Motevallian, M. Mahmoudian, Effects of pioglitazone on erectile dysfunction in sildenafil poor-responders: a randomized, controlled study. J. Pharm. Pharm. Sci. 11, 22\u201331 (2008). https:\/\/doi.org\/10.18433\/J3TG6H","journal-title":"J. Pharm. Pharm. Sci."},{"key":"3878_CR207","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/J.1365-2265.2012.04510.X","volume":"78","author":"S Sridhar","year":"2013","unstructured":"S. Sridhar, R. Walia, N. Sachdeva, A. Bhansali, Effect of pioglitazone on testosterone in eugonadal men with type 2 diabetes mellitus: a randomized double-blind placebo-controlled study. Clin. Endocrinol. (Oxf.) 78, 454\u2013459 (2013). https:\/\/doi.org\/10.1111\/J.1365-2265.2012.04510.X","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"3878_CR208","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1124\/MOL.106.028902","volume":"71","author":"P Kempn\u00e1","year":"2007","unstructured":"P. Kempn\u00e1, G. Hofer, P.E. Mullis, C.E. Fl\u00fcck, Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2. Mol. Pharmacol. 71, 787\u2013798 (2007). https:\/\/doi.org\/10.1124\/MOL.106.028902","journal-title":"Mol. Pharmacol."},{"key":"3878_CR209","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/JCB.29388","volume":"121","author":"MM Hasan","year":"2020","unstructured":"M.M. Hasan, A.S. El-Shal, A.M.H. Mackawy, E.M. Ibrahim, E.M.M.A. Abdelghany, A.A. Saeed, J. El-Gendy, Ameliorative effect of combined low dose of Pioglitazone and omega-3 on spermatogenesis and steroidogenesis in diabetic rats. J. Cell Biochem. 121, 1524\u20131540 (2020). https:\/\/doi.org\/10.1002\/JCB.29388","journal-title":"J. Cell Biochem."},{"key":"3878_CR210","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/ANTIOX11020191","volume":"11","author":"K El-Sayed","year":"2022","unstructured":"K. El-Sayed, D.A. Ali, S.A. Maher, D. Ghareeb, S. Selim, S. Albogami, E. Fayad, E. Kolieb, Prophylactic and Ameliorative Effects of PPAR-\u03b3 Agonist Pioglitazone in Improving Oxidative Stress, Germ Cell Apoptosis and Inflammation in Gentamycin-Induced Testicular Damage in Adult Male Albino Rats. Antioxid. (Basel) 11, 191 (2022). https:\/\/doi.org\/10.3390\/ANTIOX11020191","journal-title":"Antioxid. (Basel)"},{"key":"3878_CR211","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/S00125-018-4675-2","volume":"61","author":"JW Eriksson","year":"2018","unstructured":"J.W. Eriksson, P. Lundkvist, P.A. Jansson, L. Johansson, M. Kvarnstr\u00f6m, L. Moris, T. Miliotis, G.B. Forsberg, U. Ris\u00e9rus, L. Lind, J. Oscarsson, Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study. Diabetologia 61, 1923\u20131934 (2018). https:\/\/doi.org\/10.1007\/S00125-018-4675-2","journal-title":"Diabetologia"},{"key":"3878_CR212","doi-asserted-by":"publisher","first-page":"e3413","DOI":"10.1002\/DMRR.3413","volume":"37","author":"F Coelho","year":"2021","unstructured":"F. Coelho, S. dos, M. Borges-Canha, M. von Hafe, J.S. Neves, C. Vale, A.R. Leite, D. Carvalho, A. Leite-Moreira, Effects of sodium-glucose co-transporter 2 inhibitors on liver parameters and steatosis: A meta-analysis of randomized clinical trials. Diab. Metab. Res. Rev. 37, e3413 (2021). https:\/\/doi.org\/10.1002\/DMRR.3413","journal-title":"Diab. Metab. Res. Rev."},{"key":"3878_CR213","doi-asserted-by":"publisher","first-page":"865","DOI":"10.33594\/000000178","volume":"53","author":"L Uthman","year":"2019","unstructured":"L. Uthman, A. Homayr, R.P. Juni, E.L. Spin, R. Kerindongo, M. Boomsma, M.W. Hollmanna Benedikt Preckel, P. Koolwijk, V.W.M. Van Hinsbergh, C.J. Zuurbier, M. Albrecht, N.C. Weber, Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor \u03b1-Stimulated Human Coronary Arterial Endothelial Cells. Cell Physiol. Biochem. 53, 865\u2013886 (2019). https:\/\/doi.org\/10.33594\/000000178","journal-title":"Cell Physiol. Biochem."},{"key":"3878_CR214","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/ANDR.12754","volume":"8","author":"VA Giagulli","year":"2020","unstructured":"V.A. Giagulli, M. Castellana, M.D. Carbone, C. Pelusi, M.I. Ramunni, G. De Pergola, E. Guastamacchia, V. Triggiani, Weight loss more than glycemic control may improve testosterone in obese type 2 diabetes mellitus men with hypogonadism. Andrology 8, 654\u2013662 (2020). https:\/\/doi.org\/10.1111\/ANDR.12754","journal-title":"Andrology"},{"key":"3878_CR215","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3390\/IJMS24021703","volume":"24","author":"R Nevola","year":"2023","unstructured":"R. Nevola, R. Epifani, S. Imbriani, G. Tortorella, C. Aprea, R. Galiero, L. Rinaldi, R. Marfella, F.C. Sasso, GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives. Int. J. Mol. Sci. 24, 1703 (2023). https:\/\/doi.org\/10.3390\/IJMS24021703","journal-title":"Int. J. Mol. Sci."},{"key":"3878_CR216","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EC-18-0514","volume":"8","author":"M Jensterle","year":"2019","unstructured":"M. Jensterle, A. Podbregar, K. Goricar, N. Gregoric, A. Janez, Effects of liraglutide on obesity-associated functional hypogonadism in men. Endocr. Connect. 8, 195\u2013202 (2019). https:\/\/doi.org\/10.1530\/EC-18-0514","journal-title":"Endocr. Connect."},{"key":"3878_CR217","doi-asserted-by":"publisher","first-page":"e13039","DOI":"10.1111\/AND.13039","volume":"50","author":"N Shao","year":"2018","unstructured":"N. Shao, X.Y. Yu, Y.M. Yu, B.W. Li, J. Pan, W.H. Wu, H.J. Zhang, X.F. Ma, M. Hao, H.Y. Kuang, Short-term combined treatment with exenatide and metformin is superior to glimepiride combined metformin in improvement of serum testosterone levels in type 2 diabetic patients with obesity. Andrologia 50, e13039 (2018). https:\/\/doi.org\/10.1111\/AND.13039","journal-title":"Andrologia"},{"key":"3878_CR218","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/AJG.2017.170","volume":"112","author":"S Kamal","year":"2017","unstructured":"S. Kamal, M.A. Khan, A. Seth, G. Cholankeril, D. Gupta, U. Singh, F. Kamal, C.W. Howden, C. Stave, S. Nair, S.K. Satapathy, A. Ahmed, Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis. Am. J. Gastroenterol. 112, 1495\u20131505 (2017). https:\/\/doi.org\/10.1038\/AJG.2017.170","journal-title":"Am. J. Gastroenterol."},{"key":"3878_CR219","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/J.METABOL.2017.02.014","volume":"71","author":"VG Athyros","year":"2017","unstructured":"V.G. Athyros, T.K. Alexandrides, H. Bilianou, E. Cholongitas, M. Doumas, E.S. Ganotakis, J. Goudevenos, M.S. Elisaf, G. Germanidis, O. Giouleme, A. Karagiannis, C. Karvounis, N. Katsiki, V. Kotsis, J. Kountouras, E. Liberopoulos, C. Pitsavos, S. Polyzos, L.S. Rallidis, D. Richter, A.G. Tsapas, A.D. Tselepis, K. Tsioufis, K. Tziomalos, T. Tzotzas, T.G. Vasiliadis, C. Vlachopoulos, D.P. Mikhailidis, C. Mantzoros, The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism 71, 17\u201332 (2017). https:\/\/doi.org\/10.1016\/J.METABOL.2017.02.014","journal-title":"Metabolism"},{"key":"3878_CR220","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/J.CGH.2023.04.017","volume":"22","author":"R Sharma","year":"2023","unstructured":"R. Sharma, T.G. Simon, H. Hagstr\u00f6m, P. Lochhead, B. Roelstraete, J. S\u00f6derling, E.C. Verna, J. Emond, J.F. Ludvigsson, Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease. Clin. Gastroenterol. Hepatol. 22, 749\u2013759.e19 (2023). https:\/\/doi.org\/10.1016\/J.CGH.2023.04.017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"3878_CR221","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.3390\/IJMS24097818","volume":"24","author":"JA Inia","year":"2023","unstructured":"J.A. Inia, G. Stokman, E.J. Pieterman, M.C. Morrison, A.L. Menke, L. Verschuren, M.P.M. Caspers, M. Giera, J.W. Jukema, A.M. van den Hoek, H.M.G. Princen, Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation. Int. J. Mol. Sci. 24, 7818 (2023). https:\/\/doi.org\/10.3390\/IJMS24097818","journal-title":"Int. J. Mol. Sci."},{"key":"3878_CR222","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/0026-0495(93)90272-P","volume":"42","author":"AS Dobs","year":"1993","unstructured":"A.S. Dobs, P.S. Sarma, D. Schteingart, Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Metabolism 42, 1146\u20131152 (1993). https:\/\/doi.org\/10.1016\/0026-0495(93)90272-P","journal-title":"Metabolism"},{"key":"3878_CR223","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0960-0760(91)90333-Z","volume":"38","author":"AGH Smals","year":"1991","unstructured":"A.G.H. Smals, J.J.A.M. Weusten, T.J. Benraad, The HMG-CoA reductase inhibitor simvastatin suppresses human testicular testosterone synthesis in vitro by a selective inhibitory effect on 17-ketosteroid-oxidoreductase enzyme activity. J. Steroid Biochem. Mol. Biol. 38, 465\u2013468 (1991). https:\/\/doi.org\/10.1016\/0960-0760(91)90333-Z","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"3878_CR224","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-57","volume":"11","author":"CM Schooling","year":"2013","unstructured":"C.M. Schooling, S.L. Au Yeung, G. Freeman, B.J. Cowling, The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials. BMC Med. 11, 57 (2013). https:\/\/doi.org\/10.1186\/1741-7015-11-57","journal-title":"BMC Med."},{"key":"3878_CR225","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.12688\/F1000RESEARCH.25926.1\/DOI","volume":"9","author":"M Abdel-Gabbar","year":"2020","unstructured":"M. Abdel-Gabbar, M. Esmail, M. Kandeil, A.M. El-Zanaty, The ameliorative effect of atorvastatin on serum testosterone and testicular oxidant\/antioxidant system of HFD-fed male albino rats. F1000Res. 9, 1300 (2020). https:\/\/doi.org\/10.12688\/F1000RESEARCH.25926.1\/DOI","journal-title":"F1000Res."},{"key":"3878_CR226","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/J.1445-5994.2006.01295.X","volume":"37","author":"F Yakaryilmaz","year":"2007","unstructured":"F. Yakaryilmaz, S. Guliter, B. Savas, O. Erdem, R. Ersoy, E. Erden, G. Akyol, H. Bozkaya, S. Ozenirler, Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study. Intern. Med. J. 37, 229\u2013235 (2007). https:\/\/doi.org\/10.1111\/J.1445-5994.2006.01295.X","journal-title":"Intern. Med. J."},{"key":"3878_CR227","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1111\/J.1572-0241.2003.08699.X","volume":"98","author":"SA Harrison","year":"2003","unstructured":"S.A. Harrison, S. Torgerson, P. Hayashi, J. Ward, S. Schenker, Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 98, 2485\u20132490 (2003). https:\/\/doi.org\/10.1111\/J.1572-0241.2003.08699.X","journal-title":"Am. J. Gastroenterol."},{"key":"3878_CR228","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMOA0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"A.J. Sanyal, N. Chalasani, K.V. Kowdley, A. McCullough, A.M. Diehl, N.M. Bass, B.A. Neuschwander-Tetri, J.E. Lavine, J. Tonascia, A. Unalp, M. Van Natta, J. Clark, E.M. Brunt, D.E. Kleiner, J.H. Hoofnagle, P.R. Robuck, Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362, 1675\u20131685 (2010). https:\/\/doi.org\/10.1056\/NEJMOA0907929","journal-title":"N. Engl. J. Med."},{"key":"3878_CR229","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","volume":"142","author":"ER Miller","year":"2005","unstructured":"E.R. Miller, R. Pastor-Barriuso, D. Dalal, R.A. Riemersma, L.J. Appel, E. Guallar, Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142, 37\u201346 (2005). https:\/\/doi.org\/10.7326\/0003-4819-142-1-200501040-00110","journal-title":"Ann. Intern. Med."},{"key":"3878_CR230","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1874609811104020158","volume":"4","author":"LE Abner","year":"2011","unstructured":"L.E. Abner, A.F. Schmitt, S.M. Mendiondo, L.J. Marcum, J.R.: Kryscio, Vitamin E and all-cause mortality: a meta-analysis. Curr. Aging Sci. 4, 158\u2013170 (2011). https:\/\/doi.org\/10.2174\/1874609811104020158","journal-title":"Curr. Aging Sci."},{"key":"3878_CR231","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/JAMA.2011.1437","volume":"306","author":"EA Klein","year":"2011","unstructured":"E.A. Klein, I.M. Thompson, C.M. Tangen, J.J. Crowley, S. Lucia, P.J. Goodman, L.M. Minasian, L.G. Ford, H.L. Parnes, J.M. Gaziano, D.D. Karp, M.M. Lieber, P.J. Walther, L. Klotz, J.K. Parsons, J.L. Chin, A.K. Darke, S.M. Lippman, G.E. Goodman, F.L. Meyskens, L.H. Baker, Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 306, 1549\u20131556 (2011). https:\/\/doi.org\/10.1001\/JAMA.2011.1437","journal-title":"JAMA"},{"key":"3878_CR232","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/BMJ.C5702","volume":"341","author":"M Sch\u00fcrks","year":"2010","unstructured":"M. Sch\u00fcrks, R.J. Glynn, P.M. Rist, C. Tzourio, T. Kurth, Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ 341, 1033 (2010). https:\/\/doi.org\/10.1136\/BMJ.C5702","journal-title":"BMJ"},{"key":"3878_CR233","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/ANTIOX11050875","volume":"11","author":"AT Mansour","year":"2022","unstructured":"A.T. Mansour, A.S. Alsaqufi, E.A. Omar, H.S. El-Beltagi, T.M. Srour, M.I. Yousef, Ginseng, Tribulus Extracts and Pollen Grains Supplementation Improves Sexual State, Testes Redox Status, and Testicular Histology in Nile Tilapia Males. Antioxid. (Basel) 11, 875 (2022). https:\/\/doi.org\/10.3390\/ANTIOX11050875","journal-title":"Antioxid. (Basel)"},{"key":"3878_CR234","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/14017430510035862","volume":"39","author":"R Demirbag","year":"2005","unstructured":"R. Demirbag, R. Yilmaz, O. Erel, The association of total antioxidant capacity with sex hormones. Scand. Cardiovasc. J. 39, 172\u2013176 (2005). https:\/\/doi.org\/10.1080\/14017430510035862","journal-title":"Scand. Cardiovasc. J."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03878-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03878-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03878-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T05:38:09Z","timestamp":1727761089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03878-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":234,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["3878"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03878-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]},"assertion":[{"value":"15 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}